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ABSTRACT
The molecular diagnosis o f genetic disease is o f great importance to the field o f medicine and 
medical research. Though many rare inherited diseases have been described in the medical 
literature, the inheritance pattern o f more common diseases has yet to be established. Until 
recently evolutionary disease research has been conducted either by molecular diagnosis o f those 
living with the disease or by archaeological investigations examining the morphological 
pathologies o f tissue remains. It was the purpose o f this study to design and optimize a PCR 
based multi-stepped multiplexed SNE methodology to detect P-haemoglobinopathy biomarkers 
that could be applied to degraded medical and archaeological specimens and expand upon 
previous work. In order to apply the methodology to degraded tissue samples it was 
hypothesized that the necessary increase specificity and sensitivity could be obtained by 
increasing the number o f primers used to amplify target sequences and by using the products o f 
previous PCR reactions in subsequent PCR reactions respectively. Furthermore by multiplexing 
and incorporating an SBE SNP detection methodology the amount o f time, cost, involved in 
genetic disease detection could be reduced. The optimal methodology to be followed in future 
applications consists o f three sequential steps: multiplex PCR, hemi-nested PCR, and single base 
primer extension SNP detection. It was through this methodology that multiple gene 
amplifications were produced and sequenced from dilution extracts o f 1:1000000 that exhibited 
100% homology to the reference sequence. With the increase in detection sensitivity and 
specificity, multiplex capabilities and the involvement o f SNP detection this methodology can be 
expanded to detect multiple genetic mutations/variants and be applied to medical screening, 
association studies, population mapping, identification o f individuals, evolutionary disease 
studies, and validate pre-existing research.
IX
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CHAPTER 1: INTRODUCTION
GENETIC DISEASES
A genetic disease, or disorder, is the result o f chromosomal or gene abnormalities/mutations 
present at the time o f conception. Inherited genetic diseases are the emphasis o f this study, 
whereby intact defective haploid gene(s) are passed to offspring from one or both parents. They 
can exist as single gene disorders where the disorder is the result of a single gene variant passed 
to subsequent generations. They can be inherited by one o f the following inheritance patterns: 
autosomal dominant, autosomal, recessive, X-linked dominant, X-linked recessive, Y-linked, or 
mitochondrial. Genetic disorders may be complex whereby they are inherited multifactorially or 
polygenically and they cannot thus be definitively described.
Genetic diseases are common in all races, sexes, and populations o f people. Though their 
individual frequency is low, together they affect hundreds of millions o f people. Depending on 
the genotypic mutation, genetic diseases can be phenotypically clinically silent or result in 100% 
mortality. The diagnosis, treatment and prognosis are all dependent on an individual’s DNA 
sequence. Hence, there is an increasing demand for new, fast, reliable, low cost, high 
throughput nucleic acid based genetic disease detection methodologies to not only detect but 
understand the genetic mechanisms o f inherited diseases.
STRUCTURE OF DNA
Deoxyribonucleic acid (DNA) is an organic polymer found within most organisms. It serves 
as the building blocks o f life containing instructions needed to construct components o f cells. In 
addition it contains the genetic instructions that determine the development and function o f every 
cell within an organism. The nucleus, mitochondria, and chloroplasts are, for the most part, the
1
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cellular organelles that contain DNA in eukaryotes. The combination of nuclear DNA (nDNA), 
mitochondrial DNA (mtDNA) and chloroplastic DNA (chDNA) found in photosynthetic 
organisms code all genetically determined traits ranging from metabolism to immunogenic 
characteristics (Hummel, 2003).
DNA is composed o f three biochemically distinct components; nitrogenous bases, 
phosphates, and sugars, together known as a nucleotide. The structure o f eukaryotic DNA is two 
helical chains (double stranded) coiled around the same axis, each chain consisting o f phosphate 
diester groups joining p-D-dioxyribofuranose residues with 3’ and 5’ linkages (Watson and 
Crick, 1953b). These phosphates and dioxyribose sugars, making up the backbone o f the 
molecule, are asymmetrical and run in opposite directions in an anti-parallel arrangement. This 
structure is a constant among all forms o f DNA. The chains are stabilized by the hydrogen 
bonds that exist between the pairs o f nitrogenous bases which can be in four types found as pairs 
in perpendicular planes to the helical axis (Watson and Crick, 1953a). The nitrogenous bases are 
as follows: Adenine (A), and guanine (G) are purines and cytosine (C) and thymine (T) are 
pyrimidines. The combination o f these four nitrogenous bases determines the precise function 
and coding capacity of the DNA (Luftig M, 2001). It is the sequence in which these bases exist 
that varies, leading to the different genes and alleles leading to the generation o f genetic 
variation. The nitrogenous bases bind to each other in a complimentary pattern known as base- 
pairing. G and C bind to each other through the formation o f three hydrogen bonds while A and 
T bind to each other through the formation o f two hydrogen bonds.
The overall structure o f the DNA polymer is a pair o f templates in a double helix formation 
with a right directional rotation as a result o f the combined forces phosphodiester bonds, 
hydrogen bonds, hydrophobic interactions and pi stacking (Watson and Crick, 1953a; Watson
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and Crick, 1953b). As the chains wind around each other areas of nitrogenous base pairs are 
exposed between the gaps o f the phosphate sugar backbone. These gaps are known as the major 
and minor grooves and serve as access points for protein interaction, proteins such as helicase, 
topoisomerase, and transcription factors.
Nuclear DNA is described as above, a double stranded double helical structure. The haploid 
genome is composed of up to 3 billion nucleotides long in humans (Kirk et al., 2002). In order 
for the entire human nuclear genome to fit within the confined space of the nucleus the nDNA is 
distributed amongst thirteen pairs o f compacted DNA/protein complexes known as chromosomes 
(Luftig M, 2001). The chromosomes are initially formed as 166 base pairs (bp) o f the double 
helical DNA polymer wind around an octamer o f proteins known as histones. The histones serve 
as an organizational structure that provides a region for transcription. The histone/DNA complex 
is termed nucleosome and as a whole. Each nucleosome is joined to one another by a stretch o f 
linker DNA o f 48bp and a single histone protein. Without further coiling the polymer is 
classified as chromatin (Alberts B, 1994). These nucleosomes and linker strands further coil 
upon each other six per complete turn and together are referred as a solenoid. The solenoids 
further supercoil and can be classified as chromosomes.
Nuclear genetics are inherited through Mendelian genetics or the transmission o f a double set 
o f 23 homologous chromosomes in the diploid status whereby each set is inherited through the 
combination o f one haploid gamete from each parent (Hummel, 2003). It is however the 
variations and small changes that occur within the linear sequence o f DNA comprising 
chromosomes that causes random variations leading to no identical sequence o f bases between 
individuals with the exception o f some twins (Luftig M, 2001). Thus nuclear DNA is a great 
method o f comparison and identification. As this study is o f  medical, forensic and
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anthropologic/archaeological nature chDNA will not be discussed. Though mtDNA does have 
the fore-mentioned capabilities the genetic diseases to be discussed are o f nuclear origin and 
similarly mitochondrial DNA with also be excluded.
GENETIC MUTATIONS
Genetic mutations are changes in the nucleotide sequence within a polymer o f nucleic acid, 
either DNA or ribonucleic acid (RNA). Mutations occur during cell division and under the 
exposure and influence o f chemical mutagens, ionizing radiation, ultraviolet radiation, and 
viruses (Lindahl, 1993; Lindahl and Andersson, 1972; Lindahl and Nyberg, 1972; Mitchell et al., 
2005). Some processes, such as cross linking during meiosis, are intentional and propagate 
genetic diversity. Neutral mutations exist by which the overall fitness o f an individual is 
unaltered. Similarly the majority o f mutations in humans are insignificant as our cells have 
mechanisms that proof read, repair, or dispose o f mutations.
A change in genetic information may have varying effects on health dependent on their 
structural nature and whether they affect the structure or function o f essential proteins.
Mutations in multi cellular eukaryotes can occur in somatic or germ cells. It is only those DNA 
mutations that produce a phenotypic change or remain within and individual in a carrier state that 
occur in germ cells during gametogenesis that can be inherited by offspring and are thus 
important in inherited genetic disease detection studies (Haiti, 2005). Mutations such as these 
can occur as large scale mutations that affect the structure o f the chromosome or as small scale 
that affect the nucleotide sequence o f a small number o f genes.
Chromosomal structural mutations can occur as a result o f amplification, deletions, 
translocations, insertions, inversions or loss o f heterozygosity. Since these are large scale.
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mutations such as these in human rarely result in birth and if  so usually result in failure to thrive 
decreasing the inheritance o f the mutation (Hartl, 2005). Amplifications are mutations that 
duplicate a number o f genes that result in multiple copies o f chromosomal regions and possible 
an overall increase in genetic expression. Deletions occur when a region o f genetic material is 
lost leading to the absence o f corresponding genetic expression. Translocation mutations occur 
when genetic material is exchanged from one non-homologous chromosome to another. 
Insertions occur when genetic material fi-om one chromosome is added to another. Inversions 
occur when one region is flipped in orientation. This is only significant i f  the split occurs in a 
gene or a promoter region. If  this occurs it may be silent or be a duplicate if  the corresponding 
material on the homologous chromosome is also passed to the same gamete. Finally loss o f 
heterozygosity occurs when an allele is lost by a recombinant event or a deletion in a cell that 
previously had two alleles.
Small scale insertion, deletion, and point mutations are more commonly the cause of 
inherited genetic mutations as they occur more frequently and generally reduce the fitness o f  an 
individual to a lesser degree (Hartl, 2005). Insertion mutations occur when one or more 
nucleotides are added to the sequence o f DNA. They usually occur in humans as a result o f  
replication errors during replication o f regions containing repeating elements (Alberts, 1994). 
Translation occurs by reading three nucleotide complement codons o f messenger RNA (mRNA), 
the addition of extra nucleotides results in a ffameshift and the production o f an altered protein. 
Insertion mutations may also alter the coding region o f a gene and thus cause improper splicing 
o f the transcribed mRNA also resulting in incorrect translation (Weatherall, 1976). However 
insertions at the small scale can be repaired in some cases by cellular repair mechanisms that 
excise the inserted nucleotides. Deletions are similar to insertion mutations in that they too can
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result in improper splicing o f mRNA or a ffameshift mutation however these are not reversible 
by innate repair mechanisms (Collins, 1984). Point mutations occur as a result of a malfunction 
during the replication o f DNA replication that results in the exchange o f a single nucleotide for 
another, known as a single nucleotide polymorphism (SNP) (Brookes, 1999). They can occur as 
transitions where a purine is exchanged for a purine or a pyrimidine is exchange for a pyrimidine 
or as transversions where a purine is exchanged for a pyrimidine or vice versa (Alberts, 1994). 
They are reversible i f  another point mutation occurs at the same position and the mutation is 
reversed to the original sequence. They tend to exist throughout the genome however those that 
are present in protein coding regions can be one of three classifications dependent on the 
resulting erroneous codon. Silent mutations are point mutations that code for the same amino 
acid and thus generally occur as the last nucleotide in the codon. A missense mutation codes for 
a different amino acid. This may have varying degrees o f severity on the overall structure and 
function of the resultant protein and thus fitness o f an individual (Hartl, 2005). If the exchanged 
amino acid possesses similar side chains and thus similar properties then the protein structure 
may be altered to a lesser degree (Alberts, 1994). If  a missense mutation occurs then the original 
coded amino acid is replaced by a stop codon and results in a prematurely terminated protein 
(Collins, 1984).
SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs)
Single nucleotide polymorphisms (SNPs) are an abundant form of genomic variation and are 
o f great importance to research crossing multiple disciplines and thus the development o f their 
detection techniques are at the forefront o f methodological research. Between individuals 99.9% 
o f our genome is identical, and o f that 0.1% variation approximately 90% o f which is attributed
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to SNPs (Brookes, 1999). They are therefore thought to be responsible for our individual 
defining characteristics. They are defined in humans as di-allelic single base pair positions in 
genomic DNA at which different sequence alternatives (alleles) exist in normal individuals in 
some population(s), wherein the least frequent allele has an abundance o f 1 % or greater 
(Brookes, 1999). On average they occur throughout the genome at a frequency o f 1/1000 
nucleotides (Li and Sadler, 1991 ; Wang et al., 1998). However the actual distribution o f SNPs 
can exist at frequencies below 0.1% in some coding regions or as high as 10% in some non­
coding regions (Guillaudeux et al., 1998; Horton et al., 1998; Nachman et al., 1998). The 
summation o f these numbers results in several million base pair differences between two 
individual genomes and approximately 100 000 amino acid differences between their proteomes 
(Brookes, 1999).
SNPs have forensic and paternity/maternity implications. They have the potential to replace 
existing markers as they are abundantly variant yet serve as very stable genetic markers and have 
relatively low mutation rates in comparison with other types o f genetic markers (Carlson et al., 
2001). SNPs are expected to replace existing short tandem repeat identification systems as they 
are more abundant and are thus more discriminating. Once the variants o f SNPs within the 
human genome have been mapped it is believed that their association with phenotypes will 
provide an accurate tool to differential between different populations and ethnicities to be used in 
criminal profiling techniques.
SNPs are expected to take the place o f short tandem repeat (STR) polymorphisms as markers 
in disease gene mapping, just as microsatellite markers replaced restriction fi-agment length 
polymorphism (RFLP) markers (Landegren et al., 1998).
7
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In terms o f global human population genetics and anthropologic studies SNPs can be used in 
an evolutionary context to map the divergence o f humans and chimpanzees and even the 
emergence of different populations. Appropriate sets o f SNP markers can be exploited much the 
same as mitochondrial haplotypes have been used previously or used as markers to track 
movement of ancient populations and confirm the descent o f the human race. High throughput 
cost effective detection systems have the potential to map all common human gene variants and 
thus establish SNP databases (Landegren et al., 1998). Known SNPs have been used in reverse 
genetic studies to compose ethnic backgrounds and comprehensive genetic portraits (Faerman et 
al., 2000).
The human genome project has made it apparent that nDNA SNPs play key roles in 
determining phenotypes (Larcombe et al., 2005). Most SNPs are not responsible for disease 
states as only 3-5% o f the human genome codes for the production o f proteins. However the 
SNPs located in genes can be expected or directly affect protein structure or expression levels 
and therefore represent candidate alterations for genetic mechanisms in disease and are therefore 
perfect candidates for disease detection studies (Landegren et al., 1998). Furthermore the 
specificity and sensitivity o f SNP detection techniques make it possible to analyze archaeological 
specimens for the presence o f diseases attributed by SNPs in hopes o f connecting disease 
research with the field o f Anthropology. The evolution o f disease and its impacts on ancient 
peoples can now be traced. Analysis o f cytokine SNPs of ancient people has been shown to have 
applications in understanding differential population health as the human immune system has 
evolved to allow for human survival despite exposure to infectious environmental agents.
The expanding number o f known SNPs, along with greatly improved methods to monitor 
them, now promises to offer fresh insights into human biology and pathophysiology (Landegren
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et al., 1998). They are more prevalent in the genome than microsatellites, fiimishing large sets of 
markers near or in any locus o f interest (Landegren et al., 1998). Those SNPs found outside 
coding regions can serve as biological markers, much the same as RFLPs have been used 
previously, to pinpoint disease on the human genome map as they are commonly located near a 
gene associate with a disease state. Clearly many clinical phenotypes do seem to have a genetic 
component. It is suspected that most common diseases are polygenic, meaning that the variation 
in the presence/absence o f the disease is attributable, at least in part, to polymorphisms o f 
multiple interacting genes (Kirk et al., 2002). Diseases such as cancer, cardiovascular disease, 
mental illness, autoimmune states, and diabetes, are expected to be heavily influenced by the 
patterns o f SNPs one possesses in certain key susceptibility genes yet to be identified (Brookes,
1999). Furthermore many overlapping alleles, presence of SNPs plus environmental factors may 
predispose or cause a disease state in an individual. If  a factor such as those presented above 
contributes to an increase risk or causes a disease it should be found at a higher frequency in 
individuals with that disease compared to non-diseased. Ultimately, studies into disease genetics 
are trying to determine precisely which genomic sequence variants alter function and thus have a 
pathogenic effect (Brookes, 1999). The goal o f the research community is to develop assays for 
all human SNPs and score these in large sets o f  patients plus matched non-diseased controls for 
all the complex phenotypes one wished to understand.
MOLECULAR DIAGNOSIS
Molecular diagnostics is a branch o f clinical diagnostics based upon nucleic acid 
amplification that uses primarily DNA or RNA originated either from patients or pathogens as 
the biomarker for clinical testing (Zhao, 2005). The development o f molecular diagnostic 
techniques is o f paramount importance as they have made advances in the fields o f Medicine,
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anthropology, and to some extent forensics. Importantly, they can minimize time and cost as 
diagnostic tests can be performed directly on clinical specimens without the need for culture.
The specificity and sensitivity o f diagnostic techniques allows amplification and detection o f 
previously undetected nucleic acids. They can now predict an individual’s potential risk for 
onset or screen for a specific cancer, be used to screen for disease, genetic or infectious, or be 
used for prenatal testing. In addition because o f the genetic distinction of each individual, 
molecular diagnostic techniques can be used for forensic or identity testing.
Molecular diagnostics combines various gene based amplifications technologies with highly 
sophisticated detection methods for the clinical diagnosis o f a broad range o f diseases including 
infectious diseases, cancer detection, genetic diseases as well as forensic/archaeological 
identification and population or evolution studies (Faerman et al., 2000; Zhao, 2005). However 
the most encouraging achievements o f molecular genetics in these fields such as personal 
identification o f missing, victims o f mass disasters, and historical investigations, clinical, 
evolution or otherwise, that require the analysis o f  degraded DNA in archived, forensic, and/or 
archaeological degraded specimens is still limited by methodological difficulties (Faerman et al.,
2000). Furthermore despite the dramatic success o f  identifying rare Mendelian patterns of 
inherited disease the previous techniques have yet to identify the genetic factors responsible for 
common diseases (Carlson et al., 2001). This along with the growing knowledge o f the 
predisposition role o f genetic polymorphisms associated with disease risk factors has prompted 
the need for faster, more reliable, and cost effective genotyping methods for genetic 
identification o f mutations (Xu et al., 2005). Within the scope of clinical diagnosis the 
emergence and implementation o f new technologies o f  increasing sensitivities and specificities 
will allow continual improvement o f  patient care and thus save more lives (Zhao, 2005).
10
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It can be stated that the purpose o f this study is to to design and optimize multiple molecular 
genetic disease detection systems of increasing specificity and sensitivity on modem extracts that 
can be applied to degraded tissue samples. The amplification process or gene based technologies 
to be optimized, though discussed in detail later, typically consists o f template hybridization, 
nucleic acid synthesis. There are generally three classes o f gene-based amplification 
technologies: 1) target based, which are designed to detect and amplify the target gene of 
interest; 2) probe based, which rely on amplification o f the probes that are homologous to a 
specific gene target; and 3) signal based technologies that amplify the signal rather than the gene 
target sequence (Zhao, 2005). Though each o f these technologies possesses unique advantages 
and all have the common goal o f simplifying and expediting mutation analysis, the nature o f  this 
study will only concentrate target based technologies and more specifically polymerase chain 
reaction methods.
11
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CHAPTER 2: DEGRADED DNA
D e g r a d e d  a n d  A n c ie n t  DNA
The purpose o f this study is to develop a genetic disease detection methodology that can not 
only be applied high quality extracts but is sensitive and specific enough that it can be used to 
investigate the presence o f multiple diseases in degraded medically archived samples and 
archaeological specimens. In doing so this methodology can be used to conduct multiple tests on 
preserved patient samples, confirm correct diagnosis of previously medically archived 
specimens, detect the presence and role o f disease in ancient populations, and validate any pre­
existing theories pertaining to diseases contributing to morphological changes in ancient tissue 
remains.
The development o f the PCR has made it possible to analyze ancient and degraded DNA 
sequences. The terms ancient and degraded will be used interchangeably throughout this section 
as a number o f references apply to both conditions and fail to distinguish them from each other.
It allows the amplification o f minute amounts o f DNA in the presence o f large amounts o f 
damaged and degraded DNA as well as specific amplification in the presence o f  vast amounts o f 
irrelevant environmental DNA that may remain in extracts (Handt et al., 1994). This advantage 
has permitted researchers to explore the genetic structure o f ancient samples in hope of 
answering the questions associated with the origin o f humankind, the advent o f ancient societies, 
the construction o f social organizations, migration patterns, expansions, extinctions, and the 
spread and evolution o f both genetic and infectious disease (Cipollaro et al., 2005). The study of 
degraded DNA has now matured into a research tool relevant to disciplines as diverse as forensic 
science, archaeology, conservation biology, taxonomy, zoology, all medical fields.
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When DNA is extracted from ancient/degraded remains a number o f obstacles must be 
considered. It is generally found that only a small fraction of specimens contain endogenous, 
ancient DNA (aDNA) sequences that can be amplified by the Polymerase Chain Reaction (PCR) 
(Hoss et al., 1996), thus suggesting the necessity for increased PCR cycles. O f those sample 
extracts that can be amplified the fragments are limited to a low molecular size of 40-500bp 
(Paabo, 1989) and primers should therefore be designed to amplify fragments in this range. The 
likely reason for this reduction in fragment size is damage and decay to the DNA that occurs 
over time and is characterized by strand breaks, abasic sites, miscoding lesions, and crosslinks 
(Willerslev and Cooper, 2005). This damage can be attributed to spontaneous degradation, 
and/or environmental exposure, such as low level radiation, or genotoxic chemicals (DNA 
damaging agents), and/or extraction/purification processes (Hofreiter et al., 2001; Mitchell et al., 
2005). This damage will progressively accumulate until the DNA molecule loses its integrity 
and decomposes, with an irreversible loss o f nucleotide sequence information (Paabo et ah,
2004). Therefore the occurrence o f postmortem damage in DNA extracted from archaeological 
specimens is a serious concern pertinent to the study of ancient DNA as it may make the 
application of many molecular biological techniques difficult or impossible, and/or cause 
erroneous sequence information to be obtained (Higuchi et ah, 1987; Paabo et ah, 2004).
DNA D e g r a d a t io n
DNA is a relatively unstable biological molecule. It is continually affected by destructive 
chemical forces (Handt et ah, 1994; Paabo et ah, 2004). However within the living cell, the 
integrity o f the DNA molecule is protected by cellular membranes and is continually being 
maintained by various host enzymatic repair pathways (Lindahl, 1993). In contrast to these 
processes, in vitro samples or when a cell becomes metabolically inactive (dead or dormant)
13
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DNA exhibits instability and may be spontaneously hydrolyzed, oxidized or degraded by 
endogenous nucleases (Hofreiter et ah, 2001; Mitchell et ah, 2005; Paabo et ah, 2004; Willerslev 
and Cooper, 2005) as the cellular compartments that normal sequester catabolic enzyme 
breakdown (Hofreiter et ah, 2001). In addition to these processes, insects, bacteria, and fungi 
that feed on macromolecules may be present and accelerate DNA degradation in postmortem 
samples (Paabo et ah, 2004).
Intrinsic destabilization o f a nucleotide base is a predominant method of degradation 
experienced by the DNA molecule (Mitchell et al., 2005). The instability and rate o f decay o f  its 
primary structure has been investigated and determined to favour depurination at a rate 20 times 
faster that the loss o f  pyrimidines (Lindahl and Nyberg, 1972). Instability can cause the cleavage 
o f the phosphate sugar backbone, or single strand break, as well as the loss o f a nucleotide base 
(Mitchell et ah, 2005). Furthermore at the site in which a nucleotide base has been lost the 
aldehyde form of the deoxyribose sugar is rendered vulnerable to cleavage by P-elimination.
The end product is a degraded sugar residue and DNA fragments with terminal 3’ and 5’ 
phosphate groups.
DNA is a highly hydrophilic molecule and therefore remains hydrated even in arid climates 
(Handt et ah, 1994). It is therefore apparent that in addition to molecular instability, hydrolysis 
can too result in the loss o f a nitrogenous base and formation o f strand breaks (single-stranded 
nicks) (Mitchell et ah, 2005; Paabo et ah, 2004). Single strand breaks can occur by direct 
cleavage o f the phosphodiester backbone o f the molecule (Lindahl, 1993; Willerslev and Cooper, 
2005). Alternatively, base loss, usually depurination, is more likely to occur as the glycosidic 
bonds between the nucleotide base and the sugar are the main target o f hydrolytic cleavage 
(Poinar, 2003) (Lindahl and Nyberg, 1972; Willerslev and Cooper, 2005). After a site has lost its
14
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
base, the sugar, may undergo a conformational change to its aldehyde form in which in a few 
days will undergo p-elimination cleavage and strand breakage by alkali or DNA specific 
endonucleases (Lindahl, 1993; Lindahl and Andersson, 1972). Purines are released from DNA 
molecules at a similar rate (guanine released only slightly more rapidly), whereas cytosine and 
thymine are lost at a 5% higher rate (Lindahl, 1993). Single stranded DNA depurinates at a rate 
four times that o f double stranded DNA as the double helical structure provides only a minimal 
increase in protection (Lindahl, 1993).
Hydrolytic forces additionally have the ability to deaminate, or displace amino groups fi-om 
DNA bases with secondary amino groups, and thus create a miscoding modification (Poinar, 
2003) (Lindahl, 1993; Paabo et al., 2004; Willerslev and Cooper, 2005). The conversion o f 
cytosine and its homologue 5-methylcytosine to uracil and thymine respectively are the most 
common deamination reactions (Lindahl, 1993). This reaction involves direct deamination by 
alkali-catalyzed hydrolysis or the direct attack by water on the protonated base in a general acid 
catalysed reaction and leads to C-G to T-A transversions (Cipollaro et al., 2005; Lindahl, 1993). 
Similarly deamination o f adenine and guanine may occur at reduced rates resulting in their 
conversion to hypoxanthine and xanthine respectively (Lindahl, 1993; Paabo et al., 2004). In 
contrast to hydrolytic base loss, the double helix DNA structure offers good protection against 
hydrolytic cytosine deamination occurring at a rate 0.5-0.7% that of single-stranded DNA 
molecules (Lindahl, 1993; Mitchell et al., 2005). These conversions are noteworthy as they cause 
Taq DNA polymerase to insert incorrect bases during the PCR and produce erroneous 
amplifications (Willerslev and Cooper, 2005).
The amplification o f a target DNA sequence may be limited due to the oxidative forces that 
have been subjected to it as these forces can result in major helical distortion (Lindahl, 1993).
15
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Free radicals such as peroxide radicals, hydrogen peroxide, and hydroxyl radicals can induce 
lesions that block Taq DNA polymerase’s ability to extend DNA strands and thus inhibit PCR 
(Hofreiter et al., 2001; Paabo et al., 2004). In addition to these lesions the double bonds o f both 
purines and pyrimidines, as well as the 3-4’ carbon bond o f the deoxyribose are sites that are 
highly susceptible to oxidative attack and result in ring fragmentations (Paabo et al., 2004).
These purine and pyrimidine sites of oxidative attack may lead to bases modification. Nine 
different pyrimidine and purine oxidized modifications have been identified (Hoss et al., 1996). 
O f these modified bases, those o f pyrimidines, in particular thymine, are known to be occur more 
frequently as they are more sensitive to oxidative damage (Teoule in Paabo, 1989). Pyrimidines 
are oxidatively modified to form blocking lesions known as 5-hydroxy-5-methylhydantoin and 
5-hydroxyhydantoin (Paabo et al., 2004) whose presence inversely affects one’s ability to 
amplify aDNA sequences (Hoss et al., 1996). Hydroxyl radicals commonly generate 8- 
hydroxyguanine, a base lesion that base-pairs preferentially with adenine rather than cytosine 
(Lindahl, 1993).
Crosslinking is another type o f DNA damage that can block the actions o f Taq DNA 
polymerase and hinder PCR amplification (Paabo et al., 2004). Crosslinks may occur 
intramolecularly or intermolecularly (Willerslev and Cooper, 2005). Intramolecular or 
intrastrand crosslinks arise as a result o f  alkylation between nucleotide bases (Willerslev and 
Cooper, 2005). The presence o f Maillard products can allow for the formation o f intermolecular 
crosslinks (Willerslev and Cooper, 2005). Maillard products are the result o f condensation 
reactions between sugars and the primary amino groups o f nucleic acids (Paabo et al., 2004).
Molecular instability, hydrolysis, oxidation, deamination, and crosslinking are processes that 
can contribute to the degradation o f the DNA molecule over time and jeopardize its integrity. As
16
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time passes, the cumulative effects o f damage to the DNA will be so extensive that no useful 
molecules remain (Hofreiter et ah, 2001). However, when considering certain processes, no 
correlation exists between the degree o f fragmentation and the age o f a specimen and it is 
generally agreed that the state o f DNA preservation is not necessarily related to the age o f  the 
specimen (Faerman et al., 1995; Hagelberg et al., 1991; Paabo, 1989). This m aybe due to the 
fact that said processes will reach a plateau after which they only have minimal effects (Paabo, 
1989). Alternatively the environmental conditions and temperature in which the DNA samples 
have been preserved, rather than age are o f decisive importance when considering the integrity o f 
a samples sequence (Paabo, 1989). The environmental and preservation conditions are not 
always static nor do they impose the same destructive forces upon the DNA molecule. For 
instance, under circumstances, such as rapid desiccation, low temperatures o f high salt 
concentration, nucleases can become destroyed or inactivated before all nucleic acids are 
reduced to mononucleotides (Hofreiter et al., 2001). Thus the post-mortem desiccation o f a 
sample can reduce DNA degradation. It is therefore apparent that the taphonomy o f an aDNA 
sample is an important factor when considering DNA degradation.
C o n t a m in a t io n
When attempting to amplify and sequence low copy, ancient and/or degraded DNA, 
contamination is o f utmost concern as it can lead to false positive interpretation of results. If  
contamination occurs and is in greater, non-fragmented concentrations the contaminant template 
will more likely hybridize with primers and therefore preferentially amplify in greater numbers 
than the ancient template (Gilbert, 2005). There are a number o f sources o f possible 
contamination. Each require different precautions in order to minimize their risk o f occurrence
17
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and the adequate set o f control samples and/or control amplifications (Hummel, 2003). These 
sources can be categorized into contaminations occurring by handling and those contaminated by 
manufactured products. The former can further be categorized into contaminations occurring by 
carry-over, cross contamination, and persons handling.
C o n t a m in a t io n  T h r o u g h  H a n d l in g
To fully appreciate the complexities o f contamination problems associated with handling one 
must consider the scales that are involved. Contamination can be an extremely difficult factor to 
exclude especially if  the genuine template is so rare that amplification is possible in only some of 
the reactions (Hofreiter et al., 2001). One o f the most methodological problems to overcome in 
such analyses is the presence of modem environmental contamination on the surfaces o f certain 
tissues (Kemp and Smith, 2005). Even a few molecules o f modem contaminant DNA in extracts 
prepared from ancient tissues will be amplified and lead to false interpretations o f results (Handt 
et al., 1994). Thus the application o f sodium hypochlorite is a technique that can be used to 
destroy contaminating DNA on the surface o f specimens or samples (Kemp and Smith, 2005). A 
successful, non contaminated PCR can contain 10*  ̂-  lO'^ amplified molecules in a volume of 
less than 50pL (Kwok and Higuchi, 1989). Standard procedures such as opening tubes and 
transferring liquids can create microscopic aerosol droplets that contain 10^ molecules/0.005 pL 
o f said sample that can easily be distributed on to every surface in or connected to the laboratory 
via personal movement and/or air exchange systems (Handt et al., 1996; Willerslev and Cooper,
2005). Contamination may additionally occur by any direct contact the pre-PCR sample has 
with contaminated equipment, gloves or reagents (Herrmann and Hummel, 1994).
18
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This method of contamination whereby previously amplified products are introduced into a 
pre-PCR step is known as carry-over contamination (Hummel, 2003). If  this type of 
contamination occurs all future amplifications using the same reagents may reveal the exact 
same genotype of the introduced amplification product (Hummel, 2003). Carry-over 
contamination however can be prevented by physically separating pre and post-PCR workspaces, 
adopting one-way traffic, and eliminating the exchange o f equipment or reagents between 
workspaces (Herrmann and Hummel, 1994). In addition PCR amplification from trace amounts 
o f contaminating DNA can be suppressed by the ionization o f water and formation o f free 
radicals when surfaces are misted with ddH2 0  and irradiated whereby the efficiency o f 
decontamination is dependent upon the length o f the contaminant DNA sequence, the 
components o f the solution it suspended in, and the length o f irradiation (Deragon et al., 1990).
Cross contamination in an alternative source of contamination in which sample to sample 
contamination occurs (Hummel, 2003). To minimize this method of contamination, it is 
necessary to take special consideration when performing all pre-PCR procedures (Hummel, 
2003).
It can be assumed that personnel that work or have previously worked in the laboratory or 
have handled samples may have contaminated them. When working with samples o f human or 
even Neanderthal origin it is wise to use individual specific markers, and have present and past 
personnel sequences in a database in order to identify contamination events (Hummel, 2003) if  
sample can be spared. However if  an ancient sample is severely contaminated due to handling o f 
unknown persons, it unfortunately cannot be determined through the use o f negative controls 
sample nor by the reproduction o f results in secondary facilities (Hummel, 2003). Only if  the 
knowledge of the sample’s population is known and sufficient knowledge of their mitochondrial
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sequences has been accumulated is it possible to predict what sequences can be reasonably 
expected when applied to certain mitochondrial analysis (Handt et al., 1994). An added 
difficulty exist when amplifying microbial DNA remains as many papers have suggested that an 
exceptional similarity between sequenced ancient microbial samples and the sequences o f 
contemporary ones exists (Graur and Pupko, 2001). The complete exclusion of re-colonized 
ancient materials over time is difficult i f  not impossible to obtain in ancient microbial studies 
with the passive or active movement o f cells in the environment thus supporting the need for 
independent replication (Willerslev and Cooper, 2005).
C o n t a m in a t io n  F r o m  M a n u f a c t u r e d  P r o d u c t s
Human and microbial DNA and cells are ubiquitous in all laboratory settings (Willerslev and 
Cooper, 2005). It is therefore prudent to assume that all laboratory reagents, laboratory 
equipment, and disposables purchased directly from manufacturers are potential sources of 
eontamination that exist beyond the laboratory’s influence (Hummel, 2003; Willerslev and 
Cooper, 2005). Laboratory reagents and eommercial equipment marked ‘sterile’ are not 
guaranteed to be fi*ee o f nucleie acids or even viable cells (Willerslev and Cooper, 2005). 
Products sold as ‘DNA free’ (or less than 5X10"'* mg of DNA) are based on microbiologieal 
testing, not PCR (Hummel, 2003). PCR amplification tubes, in particular have been determined 
to be sources of contamination (Hauswirth, 1994) as human mDNA, control region V, sequences 
of 121 bp have been detected in up to 90% o f tubes tested after 45 amplification cycles 
(Hummel, 2003). This can be overcome however i f  amplifying DNA sequences longer than 200- 
250 bp as autoclaving will fragment contaminant DNA (Hummel, 2003).
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A v o id in g  C o n t a m in a t io n
With contamination a great concern, strict precautions and controlled conditions exist to 
avoid contamination with extraneous DNA in PCR (Hofreiter et al., 2001). These strategies exist 
in attempt to avoid all forms o f contamination and thus false positive results. The following is a 
summary o f said summaries, some of which may be a reiteration of the information provided 
above. Complete physical separation o f pre- and post-PCR workspaces, and eliminating the 
exchange of reagents, and equipment between areas is necessary as is the adoption o f a one-way 
traffic system (Hummel, 2003). Extensive cleaning of reagents, equipment, and workspaces is 
essential with complete and effective decontamination involving prolonged ultraviolet (UV) 
irradiation exposure, baking, acid or sodium hypochlorite treatment (Herrmann and Hummel, 
1994; Willerslev and Cooper, 2005). Samples should always be kept under sterile conditions and 
separate from each other (Herrmann and Hummel, 1994). All samples should be handled only 
while wearing sterile disposable gloves and gloves should be changed between sample handling 
(Herrmann and Hummel, 1994; Hummel, 2003). Precise pipetting is essential, and performed 
only with the use o f positive displacement pipettes and/or aerosol tight tips (Hummel, 2003). 
Touching the inside o f the tubes with pipette tips should be avoided (Hummel, 2003). Despite 
these precautions, false-positive reactions may still occur due to low levels o f contaminating 
amplification products that are carried over on the skin, hair, and clothing o f the laboratory 
workers within various laboratories (Rys and Persing, 1993). However by following these steps 
provided above, one may significantly minimize the risk o f contamination and thus false 
positives.
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M o n it o r in g  C o n t a m in a t io n
By employing different types o f  controls the identification of false positives can be achieved 
the possibility o f contamination can be monitored. Negative template controls are subjected to 
the same essential procedures as the samples being analyzed (Herrmann and Hummel, 1994). A 
lack o f amplification in these samples ensures that the primers used in the amplification are only 
specific to the sample template. Therefore a negative control is one that exhibits similar 
physiochemical properties and possesses a similar state o f preservation as possible when 
compared to those under investigation (Herrmann and Hummel, 1994). For instance i f  an 
ancient human specific DNA sample is to be investigated from bone extracts, one would choose 
an animal bone from the same burial site to serve as the negative control (Herrmann and 
Hummel, 1994). A blind control undergoes all analysis procedures but does not contain any 
sample material, therefore revealing any contamination in any reagent or chemical used in the 
proeedures (Herrmann and Hummel, 1994). A no-template control or blank serves to deteet any 
amplification contaminants as it contains all PCR reagents except template (Herrmann and 
Hummel, 1994).
AUTHENTICITY OF RESULTS
Recent aDNA analysis techniques have provided the genetic information o f extinct species 
and populations (Gilbert et al., 2005) that have the power to determine the recent evolutionary 
history o f humans, domesticates, and the pathogens they harboured (Poinar, 2003). However, as 
previously stated, the amount o f amplifrable DNA differs between samples as their survival is 
dependent on the different conditions in which samples have been preserved. With very little or 
no DNA surviving in ancient samples these aDNA analysis techniques are subjected to
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sensitivity, degradation, and contamination problems that make achieving authentic results 
difficult (Gilbert et ah, 2005; Poinar, 2003).Therefore to increase the likelihood that amplified 
and sequenced aDNA samples are authentic a set o f criteria have been imposed to ensure, with 
the greatest extent possible, the authenticity o f results through meticulous replication and 
authentication (Poinar, 2003). The criteria can be found in Hofreiter, 2001 (Hofreiter et al., 
2001).
The authors argue that in the absence o f full compliance to all criteria, the reliability and 
authenticity of results can be considered uncertain (Gilbert et al., 2005). However few 
published aDNA studies appear to have adopted all these methods o f authentication (Caramelli et 
al., 2003; Cooper et al., 2001). This may be due to the fact that application of all o f these 
criteria, though designed to ensure the highest quality o f aDNA data and conclusions possible, 
can be unreasonable when considering their application to each different ancient sample type and 
preservation. It has also been suggested that the authenticity and reliability o f aDNA data arises 
from the complex interplay o f  several poorly understood areas o f knowledge, thus no definite 
answer exists as to what constitutes a reliable study (Gilbert et al., 2005).
Though these criteria are not to be dismissed, consideration should be given on a case-by- 
case basis as to whether the evidence presented is strong enough to satisfy authenticity given the 
problems (Gilbert et al., 2005). For instance one must consider cost and time required for their 
complete adoption as contamination affects samples differently (Gilbert et al., 2005). Samples 
may have been previously contaminated by related DNA present in the environment and thus 
contamination can be considered inevitable. If samples are in fact contaminated prior to analysis 
these criteria provide no way to detect so. In addition when working with ancient and degraded 
samples often very little sample exists thus limiting the application o f all criteria.
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CHAPTER 3: METHODOLOGICAL BACKGROUND 
SAMPLES
Genetic disease testing in a medical scenario is a tool used to diagnose the presence or 
absence o f genetic vulnerabilities to disease or to establish ancestry. It is generally used as a 
diagnostic method in conjunction with an individual’s medical history, physical, and any 
associated medical tests/imaging (Bickley, 2007). Available types of testing include prenatal 
screening, diagnosis, newborn screening, carrier state testing, predictive and pre-symptomatie 
testing, research and even forensic testing. With the exception o f any post-mortem 
investigations, the samples to be analyzed are obtained in a manner that attempts to reduce the 
amount o f discomfort to the patient. Commonly pre-mortem tissue samples include blood, hair, 
skin, and amniotic fluid (Aula and Aula, 2006; Miller et al., 2006). When applied to post 
mortem tissue, samples may be limited and therefore a choice may not exist, nor is patient 
discomfort and issue. In all cases the extraction procedure will determine what samples can be 
analyzed.
E x t r a c t io n
The extraction process whereby DNA is separated from its host cell or place of deposition is 
by far the most crucial step in genetic analysis. A mistake at this initial stage may minimize or 
destroy the potential information preserved and retained in the sample over time (Hummel,
2003). Though less o f a concern when working with tissue samples extracted from living 
donors, optimal DNA recovery during the extraction process is o f great importance when 
working with limited ancient, degraded, or forensic tissue samples as the all subsequent stages of 
analysis are dependent on the extraction methodology (Hummel, 2003). That being said, there is 
no one extraction methodology that is optimal for all samples. Rather the method employed is
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dependent on the quality, quantity, and preservation method of the sample to be analyzed as well 
as the tissue type.
P o l y m e r a s e  C h a in  R e a c t io n
The polymerase chain reaction (PCR) is a widespread genetic research technique that serves 
to exponentially amplify a specific genetic sequence until a desired concentration is reached. 
Since its development, the PCR has been described as having transformed the manner in which 
scientific research is conducted. The technique is simplistic and its application is supported by a 
broad variety o f commercially available kits. It has proven itself as a valid method o f physically 
separating any particular sequence o f interest from its context; and then provides for an in vitro 
amplification o f this sequence virtually without limit (Mullis, 1990). The PCR provides an 
extremely sensitive and relatively straightforward means to amplify very small amounts o f DNA 
or RNA from a single copy o f a gene, to milligram amounts o f the same sequences consisting o f 
millions or billions of identical copies (Gu, 1995), a process that know takes a matter o f hours 
rather than days.
The procedure, originally described by Dr. Kary Mullis (Mullis et al., 1986), when reduced 
to its most basic terms simply involves the combination o f sample DNA with oligonucleotides 
primers, deoxynucleotide triphosphates (dNTPs), and DNA polymerase in a suitable buffer 
followed by repetitively heating and cooling the mixture for several hours until the desired 
amount o f  amplification is needed (Erlich, 1989). However one of the initial drawbacks o f this 
procedure was that o f the thermolability o f the Escherichia coli (E. coli) DNA polymerase used 
to catalyze the extension o f the annealed primers. Polymerases are necessary as they select the 
correct nucleotide to add to the primer to extend the DNA chain according to the standard 
nucleotide base pairing (McPherson, 2000). The always catalyze the synthesis o f DNA in the
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5’—>3’ direction (McPherson, 2000). The heat dénaturation step, required to separate newly 
synthesized strands o f  DNA made the addition of fresh enzyme during each cycle a necessity 
(Saiki et al., 1988). This problem was overcome through the replacement o f E. coli DNA 
polyemerase with a thermostable DNA polymerase purified from the thermophilic bacterium, 
Thermicus aquaticus {Taq), that can survive extended incubation at 95 °C (Saiki et al., 1988). 
Though it has limited chain synthesizing abilities at temperatures >90 °C, the enzyme remains 
relatively stable to and is not denatured irreversibly by exposure to high temperatures (Erlich, 
1989). Subsequent experimentation resulted in a substantial increase in the specificity, 
efficiency, and possible amplification lengths due to the increased temperature at which primer 
extension could occur (Saiki et al., 1988).
Ta q  DNA P o l y m e r a s e
Taq DNA polymerase is a 94 kDa enzymatic protein with a processivity o f 50-60 nucleotides 
and an approximate extension rate (processivity) o f 50-60 nucleotides/second at 70 °C (Innis et 
al., 1988; McPherson, 2000). It is capable o f efficiently amplifying products up to 2-4 kbp. 
Though it does have 5’ —> 3’ exonuclease proof-reading it does not possess a 3’-^ 5 ’ exonuclease 
proof-reading activity and thus incorrect nucleotide incorporations can be incorporated. This 
unfortunately results in decreased accuracy as Taq DNA polymerase will yield one base 
substitution error per 9000 nucleotides and one frameshift error per 41 000 nucleotides 
polymerized at a temperature of 70 °C (Tindall and Kunkel, 1988). If these errors occur in early 
cycles a population o f incorrect sequence amplifications may be detectable and cause false 
interpretations.
The Taq DNA Polymerase used in this project is Platinum® Taq (Invitrogen). This particular 
Taq DNA Polymerase is bound with a proprietary antibody that bocks polymerase activity at
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ambient temperatures and can only be activated by a “hot start” (the initial 94 °C dénaturation 
step). This property provides increased sensitivity, specificity, and yield by allowing mastermix 
assembly at room temperatures without the fear o f nonspecific extension or amplification. The 
manufacturer claims the use of this antibody Taq DNA Polymerase complex helps reduce PCR 
optimization requirements, reaction set-up time, and effort therefore improving PCR results.
PC R  M e t h o d o l o g y
The PCR is an in vitro method for the enzymatic synthesis o f specific DNA sequences using 
two oligonucleotide primers that hybridize to opposite strands and flank the region o f interest in 
the target DNA (Erlich, 1989). The procedure consists o f three essential temperature regimes: 
template dénaturation, primer annealing (hybridization), and extension o f annealed primers 
(elongation) (Mullis et al., 1986).
Template dénaturation is the initial phase in which the double stranded template DNA is 
separated into two complementary single strands. This is typically accomplished by increasing 
the reaction’s temperature to 94 °C for 60 s, with an initial dénaturation o f 94 °C for 5 min 
(Harris and Jones, 1997; Hummel, 2003). This amount o f high energy input provides the 
necessary force to break the hydrogen bonds between complementary bases allowing the two 
strands to separate (Harris and Jones, 1997; Hummel, 2003). Single stranded template DNA is a 
prerequisite for a successful annealing phase. The armealing phase subsequently follows 
dénaturation whereby primers anneal to their complementary single stranded sequences on the 
target DNA template. This phase is conducted at an annealing temperature (Ta) which is usually 
about 5 °C below the true melting temperature (Tm) (Harris and Jones, 1997). A fragment can 
only be amplified if  two oligonucleotides are bound to the ssDNA templates in such a way that
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the polymerase extension produet of the one contains a binding site for the other (Mullis, 1990). 
The extension phase is the final step in which a thermostable DNA polymerase synthesizes a 
complimentary copy o f the initial single strand o f DNA by incorporating dNTPs to the 3 ’ end of 
both primers making exact copies o f both strands o f DNA (Harris and Jones, 1997; Hummel, 
2003). These extension products that are created are defined by the 5’ end of the primers and 
indefinite at the 3’ ends (Erlich, 1989; Harris and Jones, 1997; Mullis et al., 1986). The 
annealing and extension phases are also typically conducted for a duration of 60 s if  the 
fragments to be amplified are o f less than 2 kb (Hummel, 2003). Two double stranded templates 
are the resultant. These three phases are subsequently repeated respectively in a series o f cycles 
whereby the products from the preceding reaction cycle serve as the reactants in the next reaction 
catalyzing a doubling, 2”, with each cycle, where n is the number of cycles (Erlich, 1989; Mullis, 
1990; Saiki et al., 1988). The end result is process in which an inherently specific exponential 
accumulation o f extension products flanked by both primer sets occurs (Harris and Jones, 1997; 
Mullis et al., 1986).
Since the first report o f  specific DNA amplification using PCR, the number of different 
applications has grown steadily, as have the modifications to the basic method. Therefore no 
single protocol can be considered appropriate, and certainly not optimal for all amplifications 
(Erlich, 1989; Harris and Jones, 1997). Optimization is always required and requires a delicate 
balance between the amplification o f specific products and the elimination o f nonspecific 
products (Harris and Jones, 1997). For instanee, the temperature at which exact dénaturation 
will occur is dependent on the size and base sequence o f the target DNA. This phase is o f 
critical importance as the DNA strand will fail to separate with inadequate heating temperature 
or time. Rather the DNA will remain in its original, more stable double stranded configuration
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thus limiting the potential o f the annealing phase (Harris and Jones, 1997). Conversely, a 
dénaturation temperature that is too high or persists for an extended period o f time may lead to 
an unnecessary loss o f DNA polymerase activity thus reducing the yield o f amplified product 
(Harris and Jones, 1997). A temperature o f 94°C will however work well in most cases as 90“- 
92°C will fully denature any sequence that has a balance GC/AT content (Erlich, 1989). The 
annealing temperature is a fundamental PCR parameter. It is found to influence both specificity 
and efficiency of amplification. The annealing temperature is dependent on the length and 
individual base pair composition o f each primer and therefore must be optimized with every new 
primer set. Lower annealing temperatures result in high efficiency amplifications with low 
specificity due to mispriming and nonspecific amplification (Chou et al., 1992; Harris and Jones, 
1997) whereas the opposite is true o f higher annealing temperatures (Harris and Jones, 1997; 
Hummel, 2003).
P r im e r  D e s ig n
The design and implementation o f PCR primers is o f paramount importance as they, more 
than any other factor, determine the success or failure o f an amplification reaction (Erlich, 1989). 
Therefore the goal of successful primer design is to obtain an optimal balance between achieving 
specificity and efficiency o f amplification (Dieffenbach et al., 1993). Efficiency is defined as 
how close a primer pair is able to amplify a product to the theoretical optimum (Dieffenbach et 
al., 1993). It requires optimization o f cycling parameters, reagent concentrations and is 
dependent on the length of both the primers and the fragment to be amplified (Dieffenbach et al., 
1993; Harris and Jones, 1997). Both o f these criteria are controlled by the intended location of 
hybridization, primer homology, primer length, amplified fragment length and the annealing 
temperature o f the PCR reaction (Dieffenbach et al., 1993; Erlich, 1989; Hummel, 2003).
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The initial step o f primer design is to determine the sequence that is to be amplified. Onee 
this is established primers are to be designed to flank the intended target sequence. The 
specificity of the reaction is ensured when the primers are a complete match with the intended 
hybridization site, are unique within the genome in focus, and are o f appropriate length 
(Hummel, 2003). Homology can be ensured by determining the primers genetic specificity 
through a “BLAST” search in GeneBank (Hummel, 2003). One must take the necessary 
precautions to avoid incorporating possible sequence polymorphisms in to the primer sequence 
(Hummel, 2003). Oligonucleotides between 18 and 24 bases in length tend to be very sequence 
specific i f  the annealing temperature o f the PCR reaction is set within a few degrees o f the 
primer Tn, (Dieffenbach et al., 1993). The optimal annealing temperature at which primers, 
under 20 bp in length will hybridize can be calculated as an estimate o f Tm, where Tm = 4(G+C) 
+ 2(A+T), whereas when calculating the Tm o f longer primers one must, employ computer 
programs to take into account thermodynamic parameters. The upper limit on primer length is 
somewhat less critical and has more to do with reaction efficiency (Dieffenbach et al., 1993). 
Shorter primers will anneal more rapidly to target DNA and form a stable double stranded 
template but m aybe less specific (Dieffenbach et al., 1993). Additional bases at the 5’ end o f 
primers can be added without affecting the annealing o f the sequence specific portion o f the 
primer. These serve as mobility modifiers, sites o f restriction digestion, or to eliminating non­
specific primer dime accumulation (Brownie et al., 1997; Dieffenbach et al., 1993).
There are a few guidelines to consider when designing PCR primers. For instance the 
primers should maintain a reasonable GC content as oligonucleotides o f 20 bases in length with 
50% G+C content have T^ values in the range of 56“-62°C (Dieffenbach et al., 1993). Primer 
pairs with poorly matched T^ can be less efficient and specific because loss o f specificity arises
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with a lower Tm and the primer with the lower Tm will have a greater chance o f mispriming 
under these conditions (Dieffenbach et al., 1993). In addition when possible, select primers with 
a random base distribution and with a GC content similar to the fragment being amplified 
(Erlich, 1989) and contain approximately equal numbers o f each nucleotide. Avoid sequences 
with significant secondary structure, particularly at the 3’ end o f the primer (Erlich, 1989).
Avoid runs of three or more G or Cs at the 3’ end as this can lead to mispriming at GC rich 
regions (McPherson, 2000). Avoid repetitive sequences or regions containing stretches o f the 
same nucleotide as this can lead to primer slippage on the template (McPherson, 2000). Check 
the primers against eaeh other for homology particularly at the 3’ end which may lead to primer 
dimer (Erlich, 1989). “Primer dimer” is a double stranded template that is approximately the 
same length as the sum o f both primers and appears to occur when one primer is extended by the 
polymerase over itself or the other (McPherson, 2000). Hairpin structures caused by self 
dimerization, and primer dimers impact reaction efficiency and should be avoided as they cause 
a drastic reduction in the reaction component resources (dNTPs, primers, etc.) (Brownie et al., 
1997; Dieffenbach et al., 1993; Hummel, 2003).
If  the information provided above is taken into consideration when designing primers, the 
specificity and efficiency of the reaction can be improved. However due to the complex 
interactions between various components with eaeh amplification conditions, cycling paramétrés 
and reagent concentrations must be established experimentally. Even after optimization one 
must still consider the template itself, if  its integrity is jeopardized the sequence to be amplified 
may not be completely intact, if  present at all.
M u l t ip l e x  PCR
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The multiplex PCR is a modification o f the original polymerase chain reaction (PCR). It 
relies on the same principles, procedures, and role o f reagents as the original but differs with the 
addition o f two or more primer sets and therefore can simultaneously amplify two or more 
specific sequences within a single reaction. Hence by combining more than one primer set the 
multiplex PCR consumes fewer reagents and offers convenience with regards to expense, time, 
and effort. The procedure was first described in 1988 (Chamberlain et al., 1988) and has since 
been successfully applied in many areas o f  DNA research such as gene deletion analysis 
(Chamberlain et al., 1988; Henegariu et al., 1994), quantitative analysis (Mansfield et al., 1993; 
Zimmermann et al., 1996), and analysis o f mutations and polymorphism (Mutirangura et al., 
1993; Rithidech et al., 1997; Shuber et al., 1993). It has proven to be a valuable tool in the 
detection o f infectious diseases (Harris et al., 1998; Hendolin et al., 1997; Heredia et al., 1996; 
Markoulatos et al., 1999) and is predicted to aid in the detection and analysis o f SNPs in ancient 
and degraded DNA samples.
Though the multiplex PCR has proven to be a beneficial research and diagnostic tool, 
similarly to singleplex, no single protocol can be considered appropriate for all amplifications. 
Multiple primers sets in a multiplex PCR are required to amplify unique target regions as pairs or 
a combination o f pairs under single reaction conditions. It is therefore necessary that all 
constituents and parameters o f newly designed multiplex PCR reactions be optimized 
empirically as they can possess inherent difficulties. Poor specificity, sensitivity, and/or 
preferential amplification of certain specific targets, problems associated with singleplex PCRs, 
may be intensified due to the presence o f more than one primer set. Thus the design o f a 
multiplex PCR is a strategic process that requires multiple attempts to optimize conditions 
(Markoulatos et al., 2003). As a result studies have been conducted in order to determine the
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factors in which the design and analysis o f a multiplex reaction can be influenced (Henegariu et 
a l, 1997; Markoulatos et al., 1999; Markoulatos et al., 2003; Markoulatos et al., 2002; 
Vandenvelde et al., 1990).
D e s ig n  a n d  O p t im iz a t io n
Primer design and implementation, as previously mentioned, is the initial and most important 
procedure when creating a multiplex. As in a singleplex PCR, the primer sequences determine 
the target sequence to be amplified, the annealing temperature, and the specificity of 
hybridization. To ensure a high quality highly specific reaction a number o f parameters must be 
taken into consideration. For optimal hybridization the primer homology for all primers must 
exhibit 100% complementation to the desired sequence to be amplified and as little 
complementation to undesired template sequences as possible. Additionally, the annealing 
temperature o f each primer must be at a low enough temperature to ensure primer hybridization 
yet it must be high enough temperature to ensure no dimerization and specific hybridization of 
all primer sets. This annealing temperature is usually between 55 and 60 “C and is established 
experimentally by the use o f a gradient PCR (Markoulatos et al., 1999). Each primer must 
therefore be designed to have similar Tm to the supplementary primers and each primer should 
not display significant homology either internally or to one another (Henegariu et al., 1997).
The annealing position o f primer sets relative to one another is o f importance when initially 
designing a multiplex PCR. If, for instance, two primers o f the same sense and equal template 
affinity are in competition with a single antisense primer, the one sense primer located one closer 
to the antisense primer has an advantage i f  the reaction is not limited by too low primer 
concentration (Repp et al., 1993). In another instance if  both sense primers bind to a single
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template molecule at the same time, the strand elongation initiated by the 5’ primer will stop at 
the position o f the 3’ primer, as this primer already blocks the template molecule (Markoulatos et 
al., 1999).
Optimal primer to template ratio is an essential concept when considering the design o f a 
multiplex PCR. Less than optimal conditions will result in the formation o f different sized non­
specific amplicons. The optimization o f a multiplex PCR should therefore aim to minimize such 
non-specific interactions. A primer concentration o f 10  ̂molar excess with respect to template is 
the standard amount added to a reaction however due to the risk o f primer dimer formation the 
primer concentration cannot be raised significantly higher than 0.5 pm regardless o f template 
concentration (Markoulatos et al., 2002). If  the ratio is too high due to a high concentration of 
primers or a low concentration o f viable template the primers will exhibit weak template- 
independent interactions with each other and give rise to primer dimers. A reaction in which the 
primer to template ratio is too low does not have the necessary amount o f primers to continue 
synthesizing amplicons from newly amplified products. The resulting effect is the renaturation 
o f denatured strands without further amplification and a reduction in exponential accumulation 
o f product occurs. If fewer than one thousand copies o f PCR template are present to be 
amplified primer dimers and other spurious artifacts caused by primer mispairing may again be 
preferentially formed thus consuming dNTPs, occupying the enzyme, further reducing desirable 
product yield, and ultimately complicating genomic information (Ruano et al., 1989; Tindall and 
Kunkel, 1988).
The concentration o f individual primers is o f importance and is a reflection o f the 
competitive nature between simultaneous DNA amplifications. Preferential amplification o f one 
target sequence over another is a common occurrence in multiplex PCRs. PCR selection and
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PCR drift have been identified as two processes that can influence this event. PCR drift occurs 
in the presence o f low template concentrations and is the result of random events occurring in the 
early cycles of a reaction (Mutter and Boynton, 1995). PCR selection however is the result o f 
differential primer affinity due to differences in the primary or secondary structure o f DNA at 
potential target sites that favour primer amplification (the target’s flanking sequence or entire 
genome) (Markoulatos et al., 2002; Wagner, 1994). Factors affecting affinity replication rates 
across template species include different melting temperatures o f different primers in the 
multiplex reaction mix. Different binding constants o f different primers at the elongation 
temperature and secondary structure formation o f templates in the annealing stage are the 
resulting effect, thereby causing stearic hindrance for primer binding (Wagner, 1994). However 
Primers o f nearly identical optimum annealing temperatures theoretically should work under 
similar conditions if  they anneal with single copy sequences. If  all the primers in a reaction 
anneal with equal efficiencies under similar conditions they can all be generally used at the same 
concentrations (Markoulatos et al., 1999). In determining primer efficiency equimolar primer 
concentrations (0.1-0.5 pM (Markoulatos et al., 2002)) should be added to the initial multiplex 
PCR (Henegariu et al., 1997). The results o f  the initial PCR will suggest how the individual 
primer concentrations and other parameters need to be changed. Observed unequal amplification 
can be corrected with an increase in the amount o f primers for the “weak” or less intense loci and 
a decrease in the amount o f primers for the “strong” primers or more intense loci. The final 
concentration o f the primers (00.4-0.5 pM) may vary considerably among the loci and is 
established experimentally (Markoulatos et al., 2002).
A delicate balance exists between dNTP and MgCE concentrations within a multiplex PCR 
reaction as the concentration o f the former is dependent on free Mg^^. The optimal dNTP
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concentration can be determined by maintaining a constant MgClz concentration of 2 mM while 
increasing dNTP concentrations stepwise from 0.5-1.6 mM (Markoulatos et al., 2002). 
Concentrations above this value rapidly inhibit amplification whereas concentrations below 
permit amplification but with reduced amount o f product yield (Markoulatos et al., 1999). This 
is because all PCR amplification reactions must contain free Mg^^ in excess o f the total dNTP 
concentration as template DNA primers and Platinum® Taq DNA polymerase (Invitrogen) must 
bind it. Platinum® Taq DNA polymerase (Invitrogen) is a magnesium-dependent enzyme that 
requires an optimal free Mĝ "̂  concentration o f 0.5 mM for its function (Markoulatos et al.,
1999). Optimization o f MgCE concentration therefore will depend on dNTP, primer and 
Platinum® Taq DNA polymerase (Invitrogen) concentrations. An excess o f  Mg^^, however, will 
favour dsDNA and stabilize its structure preventing its complete denaturization (Markoulatos et 
al., 2002). This will cause a reduction in efficiency and may lead to the stabilization o f non­
specific primer-template hybridization.
Different buffer concentrations are required for different amplification products. In general, 
primers sets with longer amplification products work better at lower salt concentrations where 
longer products become harder to denature (Henegariu et al., 1997). The opposite is true o f 
shorter amplification products. A concentration o f IX  is the recommended value for a singleplex 
PCR. In a multiplex PCR reaction the efficiency can be improved with a 2X increase in buffer 
concentration (Henegariu et al., 1997; Markoulatos et al., 2002).
Excessive Platinum® Taq DNA (Invitrogen) polymerase enzyme quantities can negatively 
affect a multiplex amplification. Unbalanced amplification at various loci and a slight increase 
in the back ground may occur possibly due to increased glycerol concentrations in the stock 
solution (Markoulatos et al., 2002). Experimentation determined that the most efficient
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concentrations o f Taq is approximately 0.4 pL or 2 U/25 pL reaction volume (Henegariu et al., 
1997). Conversely the success o f the PCR depends on the kinetic advantage that high 
concentrations o f primers have over relatively low concentrations of product. This advantage is 
lost with insufficient concentrations o f enzyme as the equilibrium will persist and DNA strands 
will rehybridize to each other, displacing annealed primers (Mullis, 1990). However as the 
extension rates and annealing specificities depends on the availability o f various other 
components and parameters in addition to the enzyme activity, modifications necessary to 
improve multiplex results must be initially directed to the former components. If  difficulty 
continues to persist in one’s multiplex reaction one can significantly improve its performance 
through the use o f adjuvants. Adujants such as DMSO, BSA, glycerol, formamide, and betaine 
when used in concentrations between 5-10% (vol/vol) improve amplification efficiency and 
specificity by relaxing the DNA molecule making template dénaturation easier (Henegariu et al., 
1997; Markoulatos et al., 2002).
The optimization process is long and difficult. It can however be facilitated if  attempted in 
the logical step-wise fashion presented above and summarized below in Figure 1.
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Figure 1: Step-by-Step Multiplex Process
The figure above presents a logical sequential process to experimentally determine the optimal reagent 
concentrations to be used in newly designed multiplex PCRs (Henegariu et al., 1997).
N e s t e d  PCR
Nonspecific amplification or complete failure to amplify may be the result o f the target 
template sequence. Given the complexity o f the human genome and the tendency for many genes 
to have some sequences in common with other related genes, a lack o f specificity is not 
uncommon in PCR amplifications (Mullis et al., 1986). Alternatively due to the cumulative
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effects o f damage to the DNA molecule postmortem DNA degradation may result in PCR 
failure (Hofreiter et ah, 2001; Hummel, 2003). aDNA extracts, for instance, do not reveal 
significant amounts o f intact targets exceeding 200bp (Hummel, 2003). The primer 
hybridization sites or sequences 3’ to these locations may simply not be present for amplification 
resulting in a failure to anneal or extend to the desired length. The nested PCR is a modified 
variation o f the original that may overcome nonspecific amplification or amplification failure.
The nested PCR is a two stage amplification employed to ensure specificity. The initial 
amplification is a simple PCR that amplifies a locus between the two hybridized 
oligonucleotides. The second stage of amplification employs one or two oligonucleotides (hemi- 
nested or nested primers) to prime within the initial amplified fragment to produce a second sub- 
firagment (Mullis et al., 1986) which may have eluded degradation. Furthermore if  a non specific 
sequence is amplified incorrectly, the probability is very low that it would be amplified again by 
a second set o f  primers. This second amplification should lead to a 10'̂  enhancement o f the 
desired product over the nonspecific (McPherson, 2000). Thus by employing two successive 
amplifications coordinated by multiple priming events, one may overcome PCR failure due to 
degradation as well as increase specificity and yield. This increased specificity provides an easy, 
direct method of verification.
DNA S e q u e n c in g
Sequencing is a valuable procedure that enables the analysis of the succession o f nucleotide 
bases within an amplified DNA fragment and thus provides a tool to identify all possible genetic 
polymorphisms (Hummel, 2003). There are a number o f different methods in which sequencing 
can be accomplished (Hindley, 1983, Wu, 1993) however the method most commonly used is
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known as Sanger sequencing and was first described by Sanger (Sanger et a l, 1977) and has 
since been modified for automation.
M e t h o d o l o g y
Sanger sequencing is essentially a single primer PCR performed subsequent to the initial 
amplification PCR (Hummel, 2003) where the purified initial PCR products serve as the template 
for the sequencing reaction. This sequencing reaction results in a DNA polymerase-directed 
synthesis o f new DNA from a single primer annealed to a single-stranded template. It initially 
requires the separation o f the preceding purified PCR product’s double strands (Sanger et al., 
1977) accomplished by a 30 second 94 “C dénaturation phase. This is subsequently followed by 
a 15 second 50 “C annealing phase whereby one primer used to initially amplify the target 
sequence is hybridized to the PCR product. The 72 °C, 4 minute extension phase is the final step 
before the cycle repeats its self as many times necessary to achieve the desired concentration o f 
sequence PCR products.
As this sequencing PCR only makes use o f  one primer the reaction is asymmetric and results 
in a linear amplification rather than an exponential amplification (Sanger et al., 1977). This is o f 
importance as the goal o f this sequencing PCR is to label all base positions with fluorescent 
2 ’,3’-dideoxynucleotides (ddNTPs) (Hummel, 2003). This is accomplished during the extension 
phase where at any base position Taq DNA polymerase can incorporate either a 2’-dinucleotide 
(dNTP) or a ddNTP that corresponds to the template base position (McPherson, 2000). The 
incorporation o f the former results in continued DNA extension as Taq DNA polymerase will 
incorporate one o f four dNTPs (either dATP, dGTP, dTTP, or dCTP depending on the 
corresponding template base) to the 3’ end of the previously incorporated dNTP and form a
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phosphodiester bond. This newly incorporated dNTP provides the 3’ site necessary to add 
another. The latter however is lacking an additional hydroxyl group (-0H) at the 3’ position 
(Sanger et al., 1977). Therefore the addition o f any one o f four ddNTPs (either ddATP, ddGTP, 
ddTTP, or ddCTP depending on the corresponding template base) to a previously incorporated 
dNTP results in the termination o f chain synthesis at its place o f incorporation by preventing the 
formation of the next phosphodiester bond (Sanger et al., 1977) (McPherson, 2000). Provided 
that the dNTPs and ddNTPs are supplied in suitable proportions only a small portion o f these 
chain termination reactions will occur at random throughout all nucleotide positions o f the 
amplified PCR product (Hummel, 2003). The majority will continue to be synthesized until the 
next position in which a proportion o f the chains will have a terminating ddNTP incorporated 
(Hummel, 2003; McPherson, 2000). The end result is a generated population o f single-stranded 
products, representing all possible lengths starting from primer plus one to primer +« terminated 
by one o f four fluorescently labeled ddNTPs (Hummel, 2003; McPherson, 2000) compliment to 
the template. After sample purification, desiccation, and resuspension in a loading buffer the 
single-stranded labeled sequences can subsequently be sorted by length and detected 
fluorescently through capillary electrophoresis (McPherson, 2000). The fluorescent signal is 
digitized and the data is analyzed producing a software generated electropherogram of a 
successive peaks o f different colours representing each of the four ddNTPs (Brandis, 1999; 
Hummel, 2003; Li et al., 1999; Rosenblum et al., 1997).
The Sanger sequencing method is a rapid and simple method of analyzing sequences. For the 
methods o f interest all the necessary reagents, minus purified amplified sample and primer, are 
contained in one reagent thus limiting contamination and time. The process does however 
possess inherent limitations. Sample preparation must be conducted on ice as the reagents may
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degrade. The Taq DNA polymerase has its own limitations as previously discussed and those 
resulting in pre-existing PCR errors as well as new ones, may be sequenced and interpreted as 
valid results.
DETECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs)
Comparison o f genomic DNA sequences in different individuals has revealed single 
positions in which two, or sometime more bases can occur (Syvanen, 2001). These single 
nucleotide polymorphisms (SNPs), as previously stated, are the most widely distributed 
polymorphisms in the human genome and have emerged as the genetic markers o f choice for 
disease studies due to their high density and relatively even distribution (Chen and Sullivan, 
2003; Kruglyak, 1999; Sachidanandam et al., 2001; Venter et al., 2001). Detection and 
interpretation o f SNPs has been recognized as a research tool o f enormous potential (Brookes, 
1999; Faerman et al., 2000; Filon et al., 1995; Kirk et al., 2002; Larcombe et al., 2005; Risch and 
Merikangas, 1996; Schork et al., 1998; Wang and Todd, 2003). Although the number o f SNP 
detection methodologies have exploded in recent years and many robust methods are currently 
available an advancement within the field o f Molecular Genetics was required to evolve fi*om 
labour intensive time consuming and expensive processes to some o f the most highly automated, 
efficient, and relatively inexpensive methods (Kwok and Chen, 2003).
The realization o f SNPs potential within the human genome first required the initial study o f 
DNA sequence variation which only became feasible after the discovery o f enzymatic and 
chemical methods o f DNA manipulation (Kwok and Chen, 2003). Since then the development 
o f random fragment length polymorphism (RFLP) genome analysis, PCR, perfection and 
optimization of sequencing techniques, and most notably the human genome project have lead to
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their appreciation. As demand for genetic analysis has increased, SNP detection technologies 
have been developed at an accelerated pace (Kwok and Chen, 2003)
Applications o f SNP analyses techniques extend from investigations o f small numbers o f 
sequence variants known to be associated with specific disease to investigations o f markers 
across the genome with markers corresponding to several variants of each of the 100000 or so 
genes (Landegren et ah, 1998). Many methods now exist to monitor as little as a single SNP to 
thousands of SNPs per assay.
These detection techniques encompass two broad areas o f research: scanning DNA 
sequences for previously unknown polymorphisms and screening (genotyping) individuals for 
known polymorphisms (Kwok and Chen, 2003). The former can further be divided into global, 
or random, approach and the regional or targeted, approach (Kwok and Chen, 2003). Though the 
nature o f this study and the techniques described and employed emphasize the latter it has the 
potential to conduct scanning investigations.
With a number o f SNP genotyping methods on the market makes the choice o f choosing the 
appropriate method difficult. The ideal SNP genotyping or otherwise detection method must 
possess the following attributes: 1) The assay must be easily and quickly developed from 
sequence information; 2) the cost o f the assay development must be low in terms o f marker 
specific reagents and time spent by expert personnel on optimization; 3) the reaction must be 
robust, such that sub-optimal DNA samples will yield reliable results; 4) the assay must be easily 
automated and must require minimal hands-on operation; 5) the data analysis must be simple, 
with automated, aceurate genotype calling; 6) the reaction format must be flexible and scalable, 
capable o f performing a few hundred to a million assays per day; and 7) once optimized, the total 
assay cost per genotype must be low (Kwok, 2001). Presently however there is no one ideal
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method that is able to meet the needs o f all SNP studies (Kwok, 2001; Kwok and Chen, 2003) 
the aim o f this study chose a specific/sensitive methodology that balanced ease for operation and 
automation with cost.
In general, SNP genotyping protocols consist o f three processes. The initial process is target 
fragment amplification, followed by allelic discrimination and finally by product/identification.
A number o f methods can be applied for each process, and they can exist in any number o f 
combinations in order to achieve an optimized protocol whereby the gain outweighs the labor 
and cost (Chen and Sullivan, 2003). The combination methods employed for this study were the 
PCR for target fragment amplification, primer extension as the method of allelic discrimination, 
and fluorescence/capillary electrophoresis as the method of allele specific product identification.
The benefits and limitations o f using PCR for target fragment amplification have been 
previously discussed in detail. In summary it works by applying heat to the extracted sample 
containing mastermix to separate a dsDNA molecule into two single stranded molecules and then 
copying each o f the two single stranded molecules with a thermostable DNA polymerase and an 
oligonuclotide primer. The end result is two dsDNA copies and when this process is repeated 
amplification of product is created exponentially. For genotyping purposes target DNA 
amplification must be specific (Chen and Sullivan, 2003). The sequence amplified must occur at 
only one locus and pseudogenes cannot exist in other gene families. Once a specific amplicon is 
determined the PCR, when optimized, ensures specificity by interrogating sequences with a 
forward and reverse primer o f  at least 18bp. Its cost and efficiency are o f concern. The PCR can 
be multiplexed to increase efficiency and decrease cost o f time and reagents however its success 
rate can drop to 50-70% and multiple targets may not be amplified equally and the number o f 
samples that can be genotyped (scoring rate) drops with an increase in targets (Chen and
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Sullivan, 2003). Furthermore the cost o f PCR can be expensive for large scale genotyping 
studies as licensing fees exist.
Following the PCR step and possible gel electrophoresis a clean-up step is required to 
remove excess dNTPs and PCR primers left over from the reaction. The clean-up is necessary 
for all primer extension based methods as the excess dNTPs and PCR primers interfere with 
primer extension SNP detection methodologies (Chen and Sullivan, 2003). This clean-up 
process is accomplished enzymatically through the addition o f shrimp alkaline phosphatase 
(SAP) and Escherichia coli exonuclease I (Exo I) followed by an incubation step. The 
incubation process, though it should be optimized consists, o f two steps. An initial prolonged 
incubation at a lower temperature, typically 30 °C for 30 minutes, subsequently followed by a 
shorter incubation at a higher temperature, typically 95-100 °C for 5 minutes. The initial serves 
to activate the enzymes and is prolonged to allow enough time for the enzymes to perform their 
function. The latter is of a high enough temperature and short enough duration to inactivate the 
enzymes. The SAP is a hydrolase enzyme that functions in an alkaline environment, engineered 
from a species o f arctic shrimp known as Pandalus borealis. This enzyme serves to 
dephosphorylate the phosphate group from the 5’ end o f nucleotides thus inactivating any 
remnant dNTPs from reaction products. The exonuclease was first described as a method to rid 
pre-PCR produets o f  smaller contaminant DNA fragments, and post PCR products o f any primer 
hybridization that could extend upon themselves in subsequent reactions (Zhu et al., 1991). This 
enzyme serves to catalyze the sequential cleavage of 5’ mononucleotides from the hydroxyl end 
o f dsDNA. Thus the two methods compliment each other preventing inappropriate extension 
and remove any carry-over components o f PCR reactions that may inhibit allelic discrimination 
reactions.
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Allelic discrimination technologies are essential genotyping tools. Their individual power of 
discrimination is dependent on the biochemical mechanism by which they operate (Chen and 
Sullivan, 2003). The mechanism determines the specificity and accuracy o f methods as well as 
the cost and throughput.
The primer extension is a method o f allelic discrimination with a DNA polymerase based 
mechanism. Though well known, the major function of a DNA polymerase is to replicate DNA 
during cell division. They are highly accurate and precise, extending an end o f a DNA strand 
and the incoming base match the template exactly (Chen and Sullivan, 2003; Syvanen, 2001). 
This approach requires amplified target DNA as a template and analyzes the products to 
determine the identity o f the base(s) incorporated at the polymorphic site (Kwok, 2001). It 
exploits that as DNA polymerases extends DNA strands from 5’ —» 3’ and require a template 
strand to guide incoming nucleotides the 3’ base must be paired with the template (Chen and 
Sullivan, 2003). However if  the 3’ extending base is not base-paired to its template DNA the 
polymerases will not add the unmatched base to the strand. In addition i f  the 3’ extending base 
is missing the 3-hydroxyl group (-OH), the extension of the strand is terminated at that 
nucleotide position as the next base cannot be added.
Primer extension allelic discrimination methods are highly flexible and require only one 
primer set per SNP position. The primer design and optimization is relatively straight forward 
and the reaction employs the same if  not similar reagents to that o f the initial PCR step (Chen 
and Sullivan, 2003; Kwok, 2001; Kwok and Chen, 2003; Syvanen, 2001). Commercially 
available DNA polymerases such as Platinum® Taq DNA polymerase (Invitrogen) do 
unfortunately exhibit substitution errors. For Platinum® Taq DNA polymerase (Invitrogen) this 
substitution error is one error for every 9000 nucleotides and a frameshift error every 41 000
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nucleotides. Although they also have 5’ —> 3’ proofreading ability which is beneficial from a 
genotyping perspective in order to repair errors and remove oligonucleotide primers used in the 
DNA replication.
Though numerous variations o f the DNA polymerase primer extension method exist the 
method o f interest is categorized as an allele specific primer extension approach (Kwok and 
Chen, 2003) but is better described as a single-base extension (SBE) (Chen and Sullivan, 2003) 
or single nucleotide extension (SNE) as it essentially extends an oligonucleotide probe 
complementary to the target amplification product by one complementary nucleotide. To ensure 
that the primer extends by only one base the triphosphate nucleotides used in the reaction are 
ddNTPs and thus do not possess a 3-hydroxyl group (Chen and Sullivan, 2003). The extension 
primers are designed a kin to PCR primers. They are approximately 20-40 bp in length with 
ideal annealing temperatures o f approximately 50 °C. If multiplexed the extension primers 
should differ in length by approximately 3-6 bp and exhibit no homology to one another. They 
are designed to anneal immediately upstream to the target polymorphic site (Chen and Sullivan, 
2003). Extension can only occur under the correct temperatures in the presence o f a DNA 
polymerase, extension primers, amplified target DNA, and candidate terminator nucleotides to 
complement the polymorphic bases. The thermocycling conditions are as follows: dénaturation 
96 °C for 10 seconds; annealing 50 °C for 15 seconds; and extension 60 °C for 30 seconds, 
generally repeated 25 times. The polymorphic bases dictate which ddNTP is incorporated. The 
product is an oligonucleotide that is one base longer than the extension primer. The product is 
once again cleaned with a SAP treatment and can now be detected.
The single-base extension products are detected by a combination o f capillary electrophoresis 
and fluorescent detection allowing a multiplexed sample to be detected based on those
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discriminatory factors. The capillary electrophoresis separates single-base extension products by 
size. The inserted ddNTP complimentary to the polymorphism is detected by fluorescence.
Each o f the four terminators is labeled with individual specific fluorophores. The detection is 
based on excitation o f a fluorescent molecule by plane-polarized light, and measurement o f the 
rate o f depolarization of fluorescence (Chen and Sullivan, 2003). This rate is proportional to the 
rate o f tumbling o f a fluorescent molecule (Syvanen, 2001). Direct fluorescence detection is 
versatile and can be done in a multiplex to a certain extent (Kwok, 2001). What is observed is a 
collective measurement o f a population o f molecules (Chen and Sullivan, 2003). Constants must 
be maintained as factors such as temperature, viscosity, and nonspecific interactions between 
fluorescent dyes and other buffer components (Chen and Sullivan, 2003). Thus deviation from a 
constant environment between samples and reactions may lead to the formation o f false positive 
or false negative results.
48
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 4: PROJECT
H A E M O G L O B I N  A N D  H A E M O G L O B I N O P A T H I E S
Haemoglobinopathies were decided to be the known disease to design and optimize a 
methodology of increasing sensitivity and specificity that could be applied to the detection of 
SNPs in this project. To understand why haemoglobinopathies are best suited to model a series 
o f methodologies leading to SNP detection systems one must understand the nature o f 
haemoglobin itself.
H A E M O G L O B I N
Haemoglobin is o f fundamental importance to the vital function o f erythrocytes. It aids to 
mediate the exchange o f  respiratory gases, oxygen and carbon dioxide, between the lungs and 
tissues (Weatherall, 1976). It allows the transport o f one hundred times more oxygen than if  
oxygen was carried dissolved in plasma alone and as humans, our activity would be restricted to 
only one fifteenth o f our present capabilities (Collins, 1984).
Structurally haemoglobin is a conjugated cytoplasmic protein. It is a spherical, globular 
molecule with a molecular weight o f 64 500 kDa. It is a tetramer consisting o f two pairs o f 
polypeptide chains known as alpha (a) and beta (P) globins with a haeme complex attached to 
each globin (Huehns, 1974). The a-globins consist o f 141 amino acids and the p-globins consist 
o f 146 amino acids. Each globin chain consists o f eight helical segments (A-H) o f nearly 
identical length and seven non helical segments allowing for bends within the structure. It 
assumes a structure in which the polar amino acids face the molecular surface and non-polar 
amino acids face the interior as it is found suspended within the aqueous cytoplasm of 
erythrocytes (Collins, 1984). The haeme complex o f a protoporphyrin ring and an iron complex
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and provides a site for oxygen (O2) to bind. The iron is in the ferrous state and remains so in an 
oxygenated or deoxygenated state. It is a tetrapyrole, consisting o f four pyrole rings. The iron 
molecule forms bonds with each o f the nitrogen atoms on the pyrole rings and with the histidine 
at globin helix F amino acid position 8 (Collins, 1984). Upon oxygenation the iron binds with 
the oxygen molecule on the opposite side o f the Histidine (His) bond to form an octahedron 
structure. The oxygen molecule will subsequently bind to the His at helix E position 7(Collins, 
1984). This iron/oxygen complex essentially is suspended in a non-polar crevice between the E 
and F helices. However it forms additional Van der Waal’s bonds with many other parts o f  the 
molecule adding to the tertiary structure.
The molecule, under normal physiologic conditions, can alter its quaternary structure into 
one o f two forms known as oxygenated and deoxygenated forms (Laberge and Yonetani, 2007). 
Upon initial oxygenation the molecule transforms its conformation to increase its affinity to 
reach a point of saturation where the preceding oxygen molecules influence the change.
Oxygen’s binding affinity is decreased in the presence o f carbon dioxide. The products o f 
cellular respiration, carbon dioxide and protons, also cause a conformational change and 
facilitates the release o f  oxygen molecules (Eaton et ah, 2007). This property amongst others is 
vital to ensure oxygen retrieval o f haemoglobin in oxygen rich environments such as the lungs, 
and its release in oxygen poor environments sueh as the body’s tissues (Weatherall, 1976).
The genetic mechanisms of the haemoglobin molecule exist on ehromosome 16 for the a- 
globins and chromosome 11 for the P-globins. The alpha and alpha-like genes and beta and beta­
like genes exist on the short (p) arms of their respective chromosomes (Collins, 1984). Two 
copies o f a-globin structural genes exist on chromosome 16, and are identical except for only 
one minor difference in the sequence o f the second intron. Upstream is a pseudo-alpha gene that
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closely resembles the sequence o f the alpha genes however a mutation exists within it that 
renders it non-functional. Further upstream from this are two embryonic like genes, one o f 
which is not expressed. The beta gene complex comprises 6 genes, an embryonic gene, two fetal 
genes (only one amino acid difference), a pseudo beta gene, 8 gene (insignificant), and the beta 
gene itself on chromosome 11 (Collins, 1984). In both gene clusters the genes are arranged in 
their order o f expression during development. All functional globin genes share a common 
general structure consisting o f three exons and two introns. Both clusters also possess a 
promoter region approximately lOObp immediately preceding the point o f transcription.
H A E M O G L O B I N O P A T H I E S
Haemoglobinopathies can be defined as genetic diseases that result in structurally abnormal 
haemoglobin molecules (Huehns, 1974). They are caused by mutations in the genetic sequence. 
Their genetic mechanism, prevalence, severity and impact on global populations make them 
perfect genetic diseases to design and optimize disease detection methodologies that have the 
potential to expand to more complex diseases and apply to archived specimens (Faerman et ah, 
2000; Filon et ah, 1995).
As previously described, the genes that code for the a- and P-globin molecules are located on 
the 16* and 11* chromosome respectively. These regions, unless affected by large scale 
chromosomal replication or sorting errors are inherited by classic Mendelian patterns of 
inheritance (Collins, 1984; Weatherall and Clegg, 1976). They can exhibit autosomal co­
dominance where symptoms are produced in a heterozygous state. Alternatively they can exhibit 
a recessive inheritance pattern. Those that are recessively inherited are less likely to be 
originated as a result o f a mutation on the alpha gene as it has two copies from each gamete
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whereas there is only one beta gene per haploid genotype. There are over 400 known structural 
haemoglobin variants (Fucharoen et al., 2002). The variants are prevalent in different 
populations at different frequencies and may even serve as a tool to track populations 
(Weatherall and Clegg, 2001). Many genetic variations are either inherited recessively, only 
occur on one alpha gene, or are just clinically silent. There are over 700 known variants o f 
haemoglobin linked diseases, over 400 of which are attributed to known haemoglobinopathies. 
277 o f the known haemoglobinopathies occur as a result o f a mutation on the beta gene and 242 
o f which occur as a result o f a SNP (Weatherall and Clegg, 2001).
Haemoglobinopathies, whether phenotypically homozygous or genotypically heterozygous 
have high prevalence in certain regions throughout the world. This can be attributed to the fact 
that certain heterozygous states are selected for as a protection mechanism o f such tropical 
diseases as malaria (Angel, 1966; Buchanan et al., 2004). The following is a 2001 global 
summary o f approximate numbers o f annual births o f babies with severe haemoglobin disorders 
(Weatherall and Clegg, 2001) modified from a 1989 study (WHO, 1989);
Region Population (XIO*) Annual Births (XIO*) Annual Affected Births 
(X1(P)
Sub-Saharan Africa 650 30 230
Americas 730 17.5 5




Western Pacific 30 0.5 0.2
Total 5340 143.0 356.8
Based on the data presented in Table 1, it is apparent that hundreds o f thousands o f individuals 
are estimated to be bom with a severe haemoglobinopathy. O f these haemoglobinopathies, 
severe abnormal haemoglobin S (Hb S) also known as Sickle Cell Anemia, Hb C, Hb D Punjab,
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Hb E, and Hb O are known as the common abnormal haemoglobins and reach high frequencies 
(Fucharoen et ah, 2002; Weatherall and Clegg, 2001). Each affects millions o f individuals 
worldwide.
The severity o f haemoglobinopathies is dependent on the pattern o f inheritance and the 
mutated gene (Steinberg, 1998). As previously mentioned some may be clinically silent whereas 
other present as severe haemolytic anemia that will result in eventual death if  left untreated 
(Buchanan et ah, 2004). Unfortunately those that are most severe are also most prevalent. Hb S 
is prevalent particularly in a broad zone o f equatorial Africa extending coast to coast and is a 
cause of haemolytic anemia. The highest incidence occurs in the eastern region o f the continent 
40-50% of the members o f certain tribes are affected in some form (Weatherall and Clegg,
2001). On average however this zone has an incidence of 10-20%. It is also found in non- 
African populations. A prevalence o f 25% has been reported in some areas o f Turkey, Saudi 
Arabia, Israel, and Southern India. It is common in some areas o f Greece and along the northern 
Mediterranean shore. Isolated cases have been observed in Caucasian Americans. Hb C greatest 
prevalence is found in Western Africa east o f the River Niger where 3% of black population 
carries the Hb C gene either as a heterozygote or homozygote (Livingstone, 1895). Hb E is 
found most commonly in SE Asia where an estimated 30 million people may carry the gene. Hb 
D Punjab is found in low percentages India through to the middle-east (Rees et al., 1998).
The severity and prevalence of these diseases has impacted global populations throughout 
time (Hershkovitz et al., 1997). The diseases are ancient, as they provided genetic protection in 
the heterozygous state against the prevalence o f malaria that followed the establishment o f 
permanent settlements near standing water in the Neolithic period (Filon et al., 1995). This 
explains their present day prevalence within the equatorial regions.
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Haemoglobinopthies are the ideal family o f inherited genetic variances to optimize and 
design detection methods of increasing sensitivity and specificity. It has been stated that they 
obey classic Mendelian patterns, the cost and time can be reduced as the most prevalent and 
severe forms are the result o f mutations occurring within a few small regions in the beta gene 
and they are attributed by SNPs. Furthermore when optimized for sensitivity and specificity, due 
to their relative confinement within the genome, large fragments of preserved DNA are not 
required. The methodologies developed to analyze the p-globin exons can be applied to any and 
all medically archived and archaeological specimens fi*om areas with high frequency or 
prevalence in order to support pre-existing results and develop new theories as to the impact and 
evolution of the disease.
Until recently the evolutionary study o f haemoglobinopathies has been extrapolated from the 
distribution o f present day mutations in different modem populations (Filon et al., 1995) or it has 
attempted to identify disease in skeletal remains on the basis o f bone pathology. The 
establishment o f differential anemias in archaelogical, skeletal and blood specimens remains 
difficult and many difficulties and méthodologie problems in analyzing DNA obtained fi-om 
archaeological specimens still exist (Faerman et al., 2000; Filon et al., 1995). It is this hope that 
the developed methodologies will help bridge that gap. Previous studies have been conducted in 
attempt to already do so. Methodologies have been developed that analyzed bone lesions from 
skeletal remains that were traced back to Israel during the time o f the Ottoman in Empire, 
suggestive of anemia. DNA analysis confirmed the genetic mechanism causing disease as a 
mutant haemoglobin allele (Filon et al., 1995). In 2000 a hotstart PCR was developed and 
successfully amplified DNA from an Jamaican male who deceased in 1993 (Faerman et al., 
2000). This study used reverse genetics to compose an ethnic background and a comprehensive
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genetic portrait o f the deceased individual. The mitochondrial and Y chromosome studies 
confirmed the individual’s West-African descent consistent with the historical account o f 
Africans brought to Jamaica during the trans-Atlantic slave trade. Furthermore the presence o f 
anemic skeletal lesions was confirmed by DNA analysis as the individual was homozygotic HbS.
Through the optimization o f newer more advanced detection methods it is the purpose o f this 
study to expand upon its predecessors by developing a multi-stepped, multiplex SNP detection 
methodology to be applied to degraded tissue samples. It is hypothesized that through 
subsequent amplifications and primer hybridizations that a methodology o f  increasing sensitivity 
and specificity can be obtained that is capable o f detecting genetic disease in degraded tissue 
samples. In doing so the hope of the study is to expand upon previous studies and bridge the gap 
between the diagnosis and study of P-haemoglobin variants in both modem and ancient 
specimens (Faerman et al., 2000; Filon et al., 1995). In accomplishing so it is hypothesized that 
further contribute to the research they have started. Through the multiplex PCRs and SNP 
detection methodologies this study can more intensely focus on the beta gene cluster while 
reducing the amount o f time, template, reagents, and cost associated with genetic diagnostics. 
Based on prevalence and frequency of the most severe haemoglobinopathies only those 
polymorphisms found within the beta gene will be detected.
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CHAPTER 5: METHODS
M ETHODOLOGICAL APPROACH
Figures 2-4 illustrate the stepwise approach taken to design and optimize individual 
methodologies that once optimized were rearranged in order to provide a final methodology of 
increasing sensitivity and specificity. A detailed explanation o f each optimization procedure can 














3. Dilution PCR1, Annealing Temperature 
Optirnizing PCR
2. Optimization of PCR 
Reagent Concentrations
Figure 2: Step 1: Process o f Singleplex Optimization o f  Amplicons I-IV Primer Sets
This procedure was conducted on the primer sets for all amplicon primer sets (Amplicons I-IV). The extract used 
was the exact same sample for each primer set to ensure continuity o f  concentration. The protocols are in sequential 
order listed from top to bottom. 1. The optimization o f  annealing temperature for each primer sets had to be 
established first. 2. Once annealing temperatures for each primer set was established the concentrations o f  each 
PCR reagent had to be established experimentally for each singleplex primer set. 3. Once annealing temperatures 
and reagent concentrations for each primer set was established a PCR conducted on a dilution series o f  the same 
purified sample using the Amplicon I and II primer sets was conducted to mimic a low copy number template and 
establish a sensitivity o f  detection. The products from these amplifications were purified and respectively served as 
the templates for Amplicon III and IV primer sets. The SBE detection primers were not optimized as singleplexes 
as the SNaPshot™ kit (Applied Biosystems) all reagent concentrations are to remain the same as indicated in the 
protocol.
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3. Dilution PCR2. Optimization of PCR 
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1. Annealing Temperature 
Optimizing PCR
Figure 3: Step2: Process o f Optimizing Multiplex and Hemi-nested Primer Sets
With the singleplex optimization o f the four primer sets completed, amplicons I and II primer sets could now be 
optimized as a multiplex PCR and amplicons III and IV could now be optimized as a hemi-nested PCR. The same 
optimization procedure as in Step 1, Figure 2 was conducted to optimize the multiplex and hemi-nested primer sets. 
2. The optimization o f PCR reagent concentrations followed the step-by-step process detailed in Figure 1. The SBE 
detection primers were not optimized as a multiplex as the SNaPshot™ kit (Applied Biosystems) all reagent 
concentrations are to remain the same as indicated in the protocol and primers were all designed with a similar 
annealing temperature. Note that the same purified extract was used to optimize both the multiplex and hemi-nested 
PCRs.
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Figure 4: Step 3; Optimized Complete Methodology Applied to Dilution Series.
Once the multiplex, hemi-nested, SNaPshot^™ methodologies were optimized individually they were combined in a 
subsequent fashion. The same purified extract used in the previous steps was used as the initial template in a 
dilution series (1:10,1:100,1:1 000, 1:10 000, 1:100 000 and 1:1 000 000). The dilution series served as the 
template for the multiplex reaction (amplicon primer sets I and II). The resulting multiplex products (amplicons I 
and II) were purified and served as the template for the subsequent hemi-nested PCR amplification. The multiplex 
PCR negative was also purified and used once again as a negative template to ensure no contamination occurred 
through the purification step. Once purified, the resulting hemi-nested products (amplicons III and IV) served as 
templates to be sequenced to detect any potential genetic mutations throughout the amplified sequences. The 
purified hemi-nested products also served as the template for SBE detection o f  multiple specific, prevalent, and 
severe (3-globinopathies at three nucleotide locations by means o f  SNaPshot™ (Applied Biosystems).
S A M P L E S
The samples tested were the roots o f facial hairs, one per extraction and only the bottom 5 
mm was used in the extraction. The root was used only if  it had a sheath in tact. Due to the time
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and cost associated with the ethical clearance o f using samples from a population, all samples 
were modem, self, and considered o f high quality.
P R O T O C O L S
The following are the protocols used throughout this project. The design and optimization o f 
methods will be discussed in later sections. These are not necessarily presented in order as one 
can deduce from Figures 2-4. Refer to Appendix A for a list of reagent lot numbers.
E X T R A C T I O N  P R O T O C O L
The process o f extracting genomic material from samples to be used for the optimization o f 
techniques or for future applications was not within the realm of this study. Although it is the 
most crucial step o f any genetic analysis the development o f optimal extraction techniques was 
not attempted, rather it was a project itself completed by a fellow colleague (Hayter, 2007).
There simply is no one extraction methodology optimal for all sample types and tophonomies. 
The method employed is dependent on the quality, quantity, and preservation method of the 
sample to be analyzed as well as the tissue type. Due to ethical restrictions and in the interest o f 
continuity, subsequent detection techniques were optimized on extracted DNA from self facial 
hair. Although exact concentrations o f nDNA within samples could not be precisely determined 
all extractions were performed using the identical extraction procedure under as identical 
environmental conditions as the laboratory could physically permit. Furthermore the same 
extraction was used to optimize each procedure to ensure continuity. It can therefore be assumed 
that all samples used in the optimization procedure are o f the same quality and quantity.
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An optimized proteinase K (prot K) enzymatic method of extraction was used for all self 
sample extractions (Hayter, 2007; Rohland and Hoffeiter, 2007). In the presence o f prot K the 
DNA is released from the cells autolytically (Hansen, 1974). This autolytic system provides a 
potentially more gentle release of DNA from cells allowing for higher molecular weight 
fragments to be isolated (Hansen, 1974). The protocol is as follows;
O p t i m i z e d  P r o t e i n a s e  K  D N A  E x t r a c t i o n  ( A p p l i e d  B io s y s t e m s )
• Using sterile techniques remove one follicle o f facial hair. Ensure that root shealth is 
present. Cut 0.5 mm from the root and place root into sterile 1.5 mL collection tube.
Add 290 pL o f TNE extraction buffer to sample.
Add 40 pL o f  2 0 %  S D S .
A d d  4 0  p L  o f  0 .3 9  M  D T T .
Add 2 pL of 20 pg/mL proteinase K.
Add 2 8  pL o f d d H z O .
Incubate tubes at 56 °C overnight with gentle agitation.
P U R I F I C A T I O N  P R O T O C O L
Post extraction the samples underwent a purification process in order to remove unwanted 
salts, low molecular weight impurities, excess prot K, and to exchange buffers. The E.Z.N.A 
Cycle-Pure Kit (United Bioinformatica Inc.) was consistently used to purify post-extract 
samples. It employs a HiBind® matrix that specifically, but reversibly, binds DNA under certain 
optimal conditions allowing proteins and other contaminants to be washed and removed. The 
DNA is easily eluted and collected with the use o f deionized water or salt buffer. The following 
procedure was performed on each extracted sample under as similar environmental conditions as 
the laboratory could physically provide:
E .Z .N .A  C y c l e  P u r e  P r o t o c o l  ( U n i t e d  B i o i n f o r m a t i c a  I n c . )
• Transfer to a clean 1.5 mL microfuge tube, and add equal volumes of Buffer X P l. For 
PCR products <200 bp add 2 volumes o f Buffer X P l. Vortex thoroughly to mix.
• Apply the sample to a HiBind® DNA spin-column assembled in a clean 2 mL collection 
tube (provided) and centrifuge in a microcentrifuge at 10,000 x g (maximum speed) for 1 
minute at room temperature. Discard the liquid.
60
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Wash the column by adding 700 pL o f SPW Buffer diluted with absolute ethanol. 
Centrifuge at 10,000 x g (maximum speed) for 1 minute at room temperature.
Discard liquid and repeat the previous step with another 700 pL SPW Buffer.
Discard liquid and centrifuge the empty column for 1 minute at 10,000 x g (maximum 
speed) to dry the column matrix. This is critical for good DNA yields.
Place column into a clean 1.5 mL microcentrifuge tube. Add 50 pL sterile deionized 
water directly onto the column matrix and centrifuge for 1 minute at 10,000 x g 
(maximum speed) to elute the DNA. This represents approximately 80-90% of bound 
DNA. An optional second elution will yield any residual DNA, though at a lower 
concentration though it was never performed.
D E T E C T I O N  P C R  P R O T O C O L
Prior to using the extracts in methodological development the purified products the 
presence o f DNA was confirmed by using previously designed primer sets that specifically 
amplified a portion o f the first exon o f the P-globin (Beaulne, 2004). All non-primer PCR 
reagents, detection PCR or otherwise were supplied by Invitrogen. The primers for all reactions 
were supplied by Operon. This PCR and each subsequent amplification procedure was 
performed under sterile conditions to prevent contamination, and performed in low light 
conditions on ice as to not to degrade reagents or purified extracts. The use o f ice and Platinum® 
Taq DNA Polymerase (Invitrogen) was employed to prevent undesirable extension product. 
Furthermore the reactions were mixed in one tube to accommodate for pipetting error. 25 pL o f 
the mastermix were subsequently aliquoted into 0.2 mL tubes. A PCR negative control (water 
and no DNA) is included to ensure reagent purity. A negative extract control is carried out to 
test for possible contamination o f the extraction procedure. An additional PCR reaction is 
prepared in case there are pipetting errors or volume preparation o f the PCR. The standard 
concentrations and order o f reagents, as well as the Platinum® Taq DNA Polymerase (Invitrogen) 
thermocycler PCR parameters for a single detection PCR amplification are listed below (Table 
2):
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Reagent Initial Concentration Final Concentration pL/Reaction
PCR Buffer lOX IX 2.5
DNTP mix 10 mM 0.2 mM 0.5
Forward Detection 
Primer (HBB 3F)
10 pM 0.2 pM 0.5
Reverse Detection 
Primer (HBB R)
10 pM 0.2 pM 0.5











D E S I G N  A N D  O P T I M I Z A T I O N  O F  M U L T I P L E X  P C R
Forward and reverse primers were designed to flank the first and second exons o f the P- 
globin gene as the majority o f prevalent and severe haemoglobinopathies are confined to these 
regions. These and all subsequent steps in the complete methodology used Accession M34058 
from GENEBank as a reference sequence. The first primer set, HBBIIF (forward) and HBBIIAR 
(reverse), was designed to amplify a region o f DNA 256 bp in length including primer 
sequences, further referred to as Amplicon I. The second primer set, ElBBIIIF (forward) and 
HBBIIIAR (reverse) was designed to amplify a region of DNA 339 bp in length, further referred 
to as Amplicon II. Unfortunately due to primer design issues, the second set could not be 
designed to efficiently flank the second exon. Hence the forward primer is designed within the
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exon. Refer to Appendix B for primer set details. The following is a diagrammatic 
representation of the relationship between the two primer sets, the sequence, and the amplicons, 
not to scale (Figure 5):









Figure 5: Map o f Amplicon 1 and II Primer Sets and Resulting Amplicons
Each primer set was optimized individually (singleplex) before optimized as a complete 
multiplex (Figure 2). This optimization required a gradient PCR to establish optimal annealing 
temperatures. Furthermore titration o f all reagents was required to establish the concentrations 
that would provide the most efficient yet specific amplification. Based on detection PCR of 
extracts the purified samples are considered to be uncontaminated. A PCR negative control 
(water and no DNA) is included to each reaction and all subsequent reactions to ensure reagent 
purity. The PCR preparation was performed as the detection PCR protocol previously described 
and under similar conditions. The following is the optimized PCR and thermocycling parameters 
for the individual HBBII and HBBIII primer sets (Tables 4 and 5):
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Reagent Initial Concentration Final Concentration pL/Reaction
PCR Buffer lOX IX 2.5
DNTP mix lOmM 0.2 mM 0.5
Forward Primer 
(HBBIIF)
10 pM 0.2 pM 0.5
Reverse Primer 
(HBBIIAR)
10 pM 0.2 pM 0.5




Table 5: Amplicon I Primer Set Thermocycling Parameters







Table 6: Amplicon II Primer Set Amplification
Reagent Initial Concentration Final Concentration pL/Reaction
PCR Buffer lOX IX 2.5
DNTP mix 10 mM 0.2 mM 0.5
Forward Primer 
(HBBIIIF)
10 pM 0.12 pM 0.3
Reverse Primer 
(HBBIIIAR)
10 pM 0.12 pM 0.3




Table 7: Amplicon II Primer Set Thermocycling Parameters
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A dilution series o f 1:10,1:100,1:1 000, 1:10 000, and 1:100 000 was applied to the 
optimized protocols amplified and sequenced in order to obtain a sample that not only behaved 
like low copy number DNA but also would serve as an initial measurement o f sensitivity to 
compare the sensitivity o f  subsequent methodologies. The Amplicon II primers were 
additionally applied to a 1:1 000 000 dilution. Each PCR product, optimized and diluted, was 
subsequently applied to AGE, Performa® DTR Gel Filtration Cartridges (Edge Biosystems) and 
sequenced according to the described protocols described later to ensure desired amplicon length 
and specific amplification.
Upon confirmation o f specific amplification, the annealing temperature, titrated reagents, and 
dilution series, the multiplex reaction was conducted and similarly optimized (Figure 3). The 
following is the optimized PCR and thermocycling parameters for the multiplex reaction using 
Amplicon I and Amplicon II primer sets (Tables 8 and 9):
Reagent Initial Concentration Final Concentration pL/Reaction
PCR Buffer lOX IX 2.5
DNTP mix 10 mM 0.2 mM 0.5
Forward Primer 
(HBBIIF)
10 pM 0.12 pM 0.5
Reverse Primer 
(HBBIIAR)
10 pM 0.12 pM 0.5
Forward Primer 
(HBBIIIF)
10 pM 0.08 pM 0.2
Reverse Primer 
(HBBIIIAR)
10 pM 0.08 pM 0.2





Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.







D e s ig n  a n d  O p t im iz a t io n  o f  H e m i-N e s t e d  M u l t ip l e x  PCR
Hemi-nested primers were designed to anneal within the purified, non-sequenced, multiplex 
amplification products. Refer to Appendix B for primer set details. The first hemi-nested 
primer, HBBIF, is a forward primer that was designed to anneal to the purified multiplex 
amplification product Amplicon I, downstream from the original HBBIIF. It in conjunction with 
HBBIIAR is to use the multiplex amplification products as a template for the next amplification 
step and production o f a 227 bp fragment further referred to as Amplicon III. The second hemi- 
nested primer, HBBIIINR, is a reverse primer that was designed to anneal to the purified 
multiplex amplification product Amplicon II upstream fi*om the original HBBIIIAR. It in 
conjunction with HBBIIIF is to use the multiplex amplification products as a template for the 
next amplification step and production o f another 234 bp fragment further referred to as 
Amplicon IV. The following is a diagramatic representation o f the relationship between the 
multiplex and the hemi-nested primers, the sequence, and the amplicons, not to scale (Figure 6):
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Exon 1 91bps Exon 2 222bps
HBBIIF HBBIF HBBIIIF
HBBIIAR HBBIIINR HBBIIIAR
1 Amplicon I . Amplicon 11
1 256bps ' 339bps
Amplicon III Amplicon IV
227bps 234bps
Figure 6: Map o f All Amplicon Primer Sets and Resulting Amplicons
Each primer set, HBBIF with HBBIIAR for Amplicon 111 and HBBIIIF with HBBIIINR for 
Amplicon IV, was optimized individually (singleplex) before optimized as a complete multiplex 
(Figure 2). This optimization required a gradient PCR establish optimal annealing temperatures. 
Furthermore, titration o f all reagents was conducted experimentally to establish the 
concentrations that would provide the most efficient yet specific amplification. Based on 
detection PCR o f extracts the purified samples are considered to be uncontaminated. A PCR 
negative control (water and no DNA) is included to each reaction and all subsequent reactions to 
ensure reagent purity. The PCR preparation was performed as the detection PCR protocol 
previously described and under similar conditions. The following is the optimized PCR and 
thermocycling parameters for the singleplex Amplicon III and Amplicon IV primer sets (Tables 
10-13):
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Reagent Initial Concentration Final Concentration pL/Reaction
PCR Buffer lOX IX 2.5
DNTP mix 10 mM 0.2 mM 0.5
Forward Detection 
Primer (HBBIF)
10 pM 0.2 pM 0.5
Reverse Detection 
Primer (HBBIIAR)
10 pM 0.2 pM 0.5




Table 11: Amplicon III Primer Set Thermocycling Parameters







Table 12: Amplicon IV Primer Set Amplification
Reagent Initial Concentration Final Concentration pL/Reaction
PCR Buffer I OX IX 2.5
DNTP mix 10 mM 0.2 mM 0.5
Forward Detection 
Primer (HBBIIIF)
10 pM 0.12 pM 0.3
Reverse Detection 
Primer (HBBIIINR)
10 pM 0.12 pM 0.3
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In order to increase sensitivity and specificity, the dilution series purified products from 
Amplicon I primer set and Amplicon II primer set were used as templates for Amplicon III and 
IV primer sets respectively (Figure 3). The Amplicon III primer set was used to further amplify 
the Amplicon I primer set 1:10 000 and 1:100 000 dilution products in order to assess i f  an 
increase in specificity could be obtained. The Amplicon IV primer set was used to further 
amplify the Amplicon II primer set 1:100,1:1 000, 1:10 000,1:100 000, and 1:1 000 000 dilution 
products. The PCR negatives used in each dilution series for the singleplex o f Amplicons I and 
II were purified, carried over and had all reagents added to serve as purification negatives. PCR 
negatives were also included for both reactions to ensure the purity o f reagents used. Each PCR 
product, optimized and diluted, was subsequently applied to AGE, Performa® DTR Gel 
Filtration Cartridges (Edge Biosystems) and sequenced according to the previously described 
protocols to ensure desired amplicon length and specific amplification. Thus the singleplex 
optimization (Figure 2) o f the hemi-nested PCR primer sets III and IV was identical to that o f  
primer sets I and II, except that for the dilution products from I and II served as the templates for 
primer sets III and IV respectively.
Upon confirmation o f specific amplification, the annealing temperature, titrated reagents, and 
dilution series, o f the singleplex hemi-nested primer sets the hemi-nested primer sets were 
multiplexed and optimized using the same optimization procedure as the multiplex optimization 
(Figure 3). Once again the purified products from the multiplex dilution served as the hemi- 
nested multiplex reaction templates to assess the increased level o f sensitivity (Figure 4). The 
PCR negative from the multiplex dilution series was once again carried over, purified, and 
applied to PCR reagents in order to serve as a purification negative. The following is the
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optimized PCR and thermocycling parameters for the hemi-nested multiplex reaction using 
Amplicon III and Amplicon IV primer sets (Tables 14 and 15);
Reagent Initial Concentration Final Concentration pL/Reaction
PCR Buffer lOX IX 2.5
DNTP mix 10 mM 0.2 mM 0.5
Forward Primer 
(HBBIF)
10 pM 0.16 pM 0.4
Reverse Primer 
(HBBIIAR)
10 pM 0.16 pM 0.4
Forward Primer 
(HBBIIIF)
10 pM 0.08 pM 0.2
Reverse Primer 
(HBBIIINR)
10 pM 0.08 pM 0.2
MgCl: 50 mM 1.5 mM 0.75
Platinum® Taq 0.2
ddHzO 16.85
DNA template - 3.0







E L E C T R O P H O R E S I S  P R O T O C O L
The detection and all subsequent PCR products are applied to 2% agarose gel electrophoresis 
(AGE) containing ethidium bromide (EtBr) and are viewed on a transluminator with ultraviolet 
(UV) light. The 2% agarose gel preparation and electrophoresis loading/running procedures are 
listed below:
A g a r o s e  G e l  E l e c t r o p h o r e s i s  P r e p a r a t i o n
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• Measure the inside o f the plate with a ruler to obtain the length and width.
L * W * 0.3 = Volume o f IXTBE to use
• Grams of agarose required = (% /100) * (Volume of IXTBE)
• Suggested Agarose Concentrations:
Table 16: The fragment sizes best analysed with each Agarose concentration






Prepare in clean flask.
Add calculated amount o f IXTBE and agarose (swirl flask to avoid clumping). **Note, if  
you are using a small boat, use 25 mL o f IXTBE and 0.375 g o f agarose to give a 
1.5% gel.
Cover flask with a polystyrene cup in which small holes have been punctured for 
ventilation.
Microwave on defrost for 90 seconds (or until agarose dissolves).
Allow gel solution to cool down (2-4 min.).
Add 2 pL Ethidium bromide (4 pL for large gel boats).
Pour the gel into the horizontal apparatus, removing all the bubbles that will affect DNA 
migration.
Insert the appropriate size comb to form wells in gel.
Allow the gel to set for ~ 45 min. at room temperature.
L o a d i n g / R u n n i n g  A g a r o s e  G e l  E l e c t r o p h o r e s i s
• Fill out a gel loading sheet.
•  Turn gel sideways in apparatus.
•  Pour IXTBE buffer in electrophoretic apparatus until gel is covered ( ~ 1 cm).
•  Remove comb carefully.
•  Purge wells with transfer pipette.
• Load wells with sample and loading dye, and one lane o f molecular marker.
• Set voltage 110 V and time at ~ 30 min. on electrophoretic apparatus.
• After gel has run, transfer to the illuminator then view it (UVB) and photograph.
POST PCR PURIFICATION PROTOCOL
After every PCR the products remaining after running AGE that were to be applied to further 
detection techniques were purified using Performa® DTR Gel Filtration Cartridges (Edge 
Biosystems). They are 0.8 mL spin columns packed with a gel matrix optimized to effectively
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remove dye dNTPs and low molecular weight materials from products. They also effectively 
remove DNA primers, fragments up 15 bases, buffers, biotin labeled nucleotides, isotope, dye 
terminators, and other assorted marker making them a suitable post-sequencing purification 
method as well. The protocol is as follows:
P e r f o r m a ®  D T R  G e l  F i l t r a t i o n  C a r t r i d g e s  ( E d g e  B i o s y s t e m s )
• Spin/centrifuge column at 3400 rpm for 2 min.
• Put column in fresh sterile tubes.
• Add samples (25-75 pL) to column.
• Centrifuge again at 3400 rpm for 2-4min (add ~ 10 pL o f ddH20 and spin for 4 min. for
optimal results.)
A B I  B I G  D Y E  T E R M I N A T O R  S E Q U E N C I N G  P R O T O C O L
The Sanger Dideoxy Method of DNA sequencing using ABI Big Dye Terminator v.3.1 Cycle 
Sequencing Kit protocols and the ABI 3100™ gel capillary electrophoresis in conjunction with 
Genescan™ software was employed as further confirmation that those fragments that were 
amplified were the desired product. The capillary electrophoresis was conducted by the Paleo- 
DNA Laboratory in Thunder Bay, Ontario and resulting electropherograms were analyzed using 
Bioedit 7.O.5.2. The sequencing also served as a tool to search the amplified products for any 
polymorphisms. The sequencing preparation was performed on ice in the dark. All reagents and 
samples kept on ice and vortexed and zipped before using. The sequencing protocol was 
performed each time as follows (Table 17):
S a n g e r  D i d e o x y  B i g  D y e  T e r m i n a t o r  S e q u e n c i n g  P r o t o c o l
• Label a sterile 0.5 mL PCR tubes.
• Centrifuge post PCR purified extractions for 1 min. at 13000 rpm.
• Prepare the following PCR for each sample on ice (Table 17).
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Reagent Volume
BDT Ready Rxn Mix 3 pL (or 4 pL)
Primer (forward or reverse) 10 
pM
0.37 pL
Sample (purified) According to gel band intensity (6-7 pL)
ddHiO Enough to make a l O p L  reaction
Prepare a master mix if  sequencing 3 or more samples with the same primer. 
Vortex PCR tubes and briefly centrifuge.
Program thermocycler: For 25-45 cycles, 
o Dénaturation = 94 °C -  30 sec.
o Annealing = 50 *̂C -  15 sec.
o Extension = 72 ®C -  4 min.
o Hold at 4 °C.
Purify using Performa® DTR Gel Filtration Cartridges.
Desiccate completely at 30 °C.
A B I  P r i s m ®  S N a P s h o U ''^  P r i m e r  E x t e n s i o n  S N P  D e t e c t i o n
The ABI Prism ABI Prism® SNaPshot^*^ primer extension method o f SNP detection was 
used as the method to detect SNPs. All steps are prepared on ice and in the dark. The protocol 
was performed as follows:
ABI Prism® SNaPshot^'^ Primer Extension Protocol
• In order to prepare samples for the reaction an additional purification is requied. To 15 
pL o f post PCR purified template add 5 pL o f SAP and 2 pi o f Exo I and incubate at 37 
°C for 1 hour followed by a 75 °C incubation for 15 minutes. Hold at 4 °C. These 
products are used for the SNaPshot™.




PCR product 3 pL
ddH20 1 pL
Primer(s) 10 pM 1 pL total
The thermocycling parameters are as follows (Table 19):
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Table 19: Thermocycler Parameters for the SNaPshot Reaction






The reaction is ready to be detected following the addition of 1 uL o f SAP incubated at 
37 °C for 1 hour and 75 °C for 15 minutes, held at 4 °C as a post purification step.
D e sig n  a n d  O p t im iz a t io n  o f  a  M u l t ip l e x  P r im e r  E x t e n s io n  S N P  
D e t e c t io n  S y s t e m
The ABI Prism® SNaPshot™ Primer Extension methodology was used to design single base 
extension primers in order to detect the presence o f SNPs within the P-globin gene. It was 
chosen as it has multiplex capacity to increase throughput and decrease cost, it differentiates 
between products based on size and fluorescence, and it is compatible with already available 
capillary DNA sequencers (Syvanen, 2001). The compatibility is o f importance as most assays, 
this one included, rely on detection methods that require highly specialized instrumentation, 
which are highly priced and not many laboratories cannot afford multiple systems (Kwok, 2001). 
This methodology uses the same gel capillary electrophoresis equipment and software as 
described in the Sanger Sequencing protocol described above.
Primers were designed to anneal to the already amplified, non-sequenced, and purified 
Amplicon III. The first primer HBBSNP6-1R is a reverse primer that will detect the first 
nucleotide at codon 6. It is at this position that the wild type genotype, or Hb Machida, or Hb C 
disease genotypes (homozygous or heterozygous) can be detected depending on which 
fluorescently labeled ddNTP is incorporated compliment to the genome. This primer produces a 
single base reverse complement extension product o f 30 bp, where the incorporation o f a C
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(black) codes for wild type, the incorporation of a G (blue) codes for the presence o f Hb 
Machida, and the incorporation o f G (red) codes for Hb C.
The second primer HBBSNP6-2R is a reverse primer that will detect the second nucleotide at 
codon 6. It is at this position that the wild type, or Hb S, or Hb G Makassar, or Hb G San Jose 
disease genotypes (homozygous or heterozygous) can be detected depending on which 
fluorescently labeled ddNTP is incorporated compliment to the genome. The primer produces a 
single base reverse compliment extension product o f 27 bp, where the incorporation o f a T (red) 
codes for wild type, the incorporation o f an A (green) codes for Hb S, the incorporation o f a G 
(blue) codes for Hb G Makassar, and the incorporation o f a C (black) codes for Hb G San Jose.
The third primer HBBSNP26 is a forward primer that will detect the first nucleotide at codon 
26. It is at this position that the wild type or Hb E disease genotype (homozygous or 
heterozygous) can be detected depending on which fluorescently labeled ddNTP is incorporated 
identical to the genome. The primer produces a single base extension product identical to the 
genome of 24 bp, where the incorporation o f a G (blue) codes for wild type, and the 
incorporation o f an A (green) codes for Hb E.
The primers were optimized resulting in their addition in equimolar amounts totaling 1 pL of 
primer total. Once the reagents were titrated the pre-purification, the primer extension, and post 
purification methods were carried out as previously described in Protocols.
The specificity o f the methodology increases as it progresses from step to step as the 
products are interrogated, annealed to, and amplified by a new set o f oligonucleotide primers of 
different sequence that must exhibit complete homology with the products nucleotide sequence 
present. The sensitivity increases as the methodology progresses there are two amplification 
procedures whereby the second amplifies the initial amplification’s products. The subsequent
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amplification allows the detection and sequencing o f a 1:1 000 000 diluted template. This is an 
increase o f 100 fold detection capabilities than with a single amplification procedure. A loss of 
sensitivity is to be expected with each purification step as the products from the preceding step 
are diluted and a 100% efficiency o f column purification is not guaranteed. Furthermore 
efficiency may decrease with each step as carry over reagents unused from the previous step may 
alter the chemical kinetics and product is lost. However these losses o f sensitivity and efficiency 
are negligible if  procedures are performed and the reagents and template are stored properly 
under the proper environmental conditions. When applying this methodology to degraded DNA 
samples contamination is o f the utmost concern. Thus the precautions outlined in the 
Introduction and sterile working environments must be obeyed
This methodology was designed to amplify and analyze the first two exons o f the P-globin 
gene in order to detect associated haemoglobinopathies. This family o f  gene and diseases was 
chosen as they obeyed the Mendelian pattern o f inheritance, many of the diseases are prevalent 
and severe, the diseases effect global populations and their distribution, and the majority o f  
diseases are attributed to SNPs. That being said this methodology can be modified. The cost, 
product loss, and risk o f contamination can be decreased by removing the electrophoresis steps at 
the expense o f losing a visual confirmation o f  desired amplification. However i f  well versed and 
confident in performing the methodology with accuracy and precision one can eliminate these 
electrophoresis steps and simply rely on sequencing to confirm specificity o f amplification.
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F I N A L  M E T H O D O L O G I C A L  A P P R O A C H




Figure 7: The Established and Optimized Methodological Approach
After all annealing temperatures, reagent concentrations, sensitivities were determined the 
optimized final methodology to be applied to modem and degraded medical and archaeological 
samples consists o f a multiplex PCR, followed by a subsequent Hemi-nested PCR amplification, 
and finally by SNaPshot^™ single based extension to be detected by capillary gel electrophoresis 
whereby the purified o f products o f the preceding procedure serve as the template for the 
subsequent procedure. Note that this methodology is to be applied to purified extracts. The 
optimal extraction/purification methodology is sample dependent.
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CHAPTER 6: RESULTS
M U L T I P L E X  P C R
The Amplicon I primer set successfully and specifically amplified its desired amplicon of 
256 bp. The annealing temperature was optimized to 63.0 °C (see Figure 8, lane 10) and the 
reagents were optimally titrated to an efficiency that successfully and specifically amplified a 
purified extract dilution o f 1:10 000 (see Figure 9, lane 5). The following are the gel captures 
confirming the annealing temperature optimization and the dilution series respectively (Figures 8 
and 9):
300bps —  
200bps —-n
12 13 14 15
Figure 8: Amplicon I Primer Set Annealing Temperature Optimization
The purified extract used as template DNA was the sample extract as all subsequent reactions. The reagent 
concentrations were the same as those described in Table 2. The thermocycling paramétrés were the same as Table 
5 with the exception o f  annealing temperatures which varied as follows: Lane 2, 55.0 °C; lane 3, 55.2 “C; lane 4,
55.7 “C; lane 5, 56.6 “C; lane 6, 57.8 “C; lane 7, 59.1 “C; lane 8, 60.5 “C; lane 9, 61.9 ”C; lane 10, 63.1 °C; lane 13,
63.7 “C; lane 14, 64.0 “C; and lane 15, 65.5 “C. Lanes 1 and 11 are 1500 bp molecular size standard and lane 12 is a 
blank lane. Lane 10, approximated to 63.0 °C was determined visually to be the optimal annealing temperature as is 
had the best intensity with the least amount o f  non-specific product.
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300bps
200bps
\n ip l ic o t i  I 
256 bn
Figure 9: Amplicon I Primer Set Dilution Series
The purified extract used as template DNA was the sample extract as all previous and subsequent reactions. The 
optimized reagent concentrations and thermocycling parameters were the same as those described in Tables 4 and 5. 
Lane 1 contained the 1500 bp molecular size standard. The dilution series products were contained in the remaining 
lanes as follows: Lane 2, 1:10; lane 3, 1:100; lane 4, 1:1 000; lane 5,1:10 000; lane 6,1:100 000; lane 7, dilution 
negative; and lane 8, PCR negative.
The Amplicon II primer set successfully and specifically amplified its desired amplicon of 
339bp. The annealing temperature was optimized to 65.0“C and the reagents were optimally 
titrated to an efficiency that successfully and specifically amplified a purified extract dilution o f 
1:1000. The following is the gel capture confirming the annealing temperature optimization and 
the dilution series (Figure 10):
200bps \m p h c o a  Ü
33V b p
Figure 10: Amplicon II Primer Set Optimized Armealing Temperature Dilution Series
The purified extract used as template DNA was the sample extract as all previous and subsequent reactions. The 
optimized reagent concentrations and thermocycling parameters were the same as those described in Tables 6 and 7. 
Lane I contained the 1500 bp molecular size standard. The dilution series products were contained in the remaining 
lanes as follows: Lane 2, 1:10; lane 3, 1:100; lane 4, LI 000; lane 5, 1:10 000; lane 6,1:100 000; lane 7,1:1 000 
000; lane 8, blank; lane 9, PCR negative; and lane 10, dilution negative.
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The amplicons in figure 10 are significant smearing and the migration o f the size standard 
does not match entirely for its desired length, nor do the desired amplicons in figures 8 and 9.
This smearing is attributed to too much DNA, which will not be an issue when applied to 
degraded samples. The undesirable length can be attributed to expired and degraded molecular 
size standard causing a difference in migration. A difference in migration can even be 
appreciated between samples as AGE is not a uniformly synthetic migration media and the comb 
that produces the lanes may not have been truly straight. The difference is millimetres. Though 
the visual confirmation is not optimal the products have been confirmed as specific through 
sequencing (Appendix C:B).
As previously stated the sequencing o f optimized amplifications and dilution series were 
conducted to ensure specificity o f amplifications. Though a discrepancy was observed on AGE 
the fact that the desired sequences were obtained one can attribute said gel observations to the 
issues discussed above. The optimized Amplicon I amplification was sequenced despite being o f 
desired length, as was its dilution series (Appendix C:A). The sequence matched 218 out o f 219 
nucleotides with 100% homology to the reference sequence. This corresponds to 99.54% 
homology. The discrepancy occurs at nucleotide position 1620, whereby a C ^  T heterozygous 
state exits at the third amino acid in exon 1 ’s codon which results in a silent mutation. This 
extract’s heterozygous state is confirmed by the reverse sequence and subsequent dilution 
sequences. The 1:1000 purified dilution series product, when sequenced, confirmed the previous 
results and displayed the same homology.
The optimized Amplicon II was sequenced, as was its dilution series to ensure the desired 
amplicon was amplified. There was 100% homology when compared to the reference sequence 
(Appendix C:B). The forward primer was not capable of sequencing the entire exon however the
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reverse did for the reasons discussed in Protocols: The Design and Optimization o f Multiplex 
PCR (Appendix C, B). Note that the purity o f  the negatives in both primer sets did not produee 
any discernable sequence.
The multiplex PCR was optimized and its sensitivity was determined upon confirmation that 
the singleplex reactions o f the Amplieon I and II primer sets were specific and they could detect 
dilutions o f 1:10 000 (Figure 9, lane 5) and 1:1 000 (Figure 10, lane 3) respectively. Its optimal 
annealing temperature was determined to be 63.0®C (Figure I I ,  lane 4) and was sensitive enough 
to detect a dilution o f 1:10 000. The following is a gel capture o f the multiplexed optimized 
annealing temperature (Figure 11):
A m p lic o n  II
A m p lic o n  I 
2 5 6  b p
Figure 11: Multiplex Primer Sets Annealing Temperature Optimization
The purified extract used as template DNA was the sample extract as all subsequent reactions. The reagent 
concentrations were the same as those described in Table 2. The thermocycling paramétrés were the same as Table 
5 with the exception o f annealing temperatures which varied as follows: Lane 2, 57.8 °C; lane 3, 60.5 “C; lane 4,
63.0 °C; and lane 5, 65.0 °C. Lane 1 contains 1500 bp molecular size standard and lane 6 contains a PCR negative. 
Lane 4, 63.0 “C was determined visually to be the optimal annealing temperature as is had the best intensity with the 
least amount o f non-specific product.
The gel capture (Figure 11) is o f poor resolution. The molecular size standard (see Figure 
I I ,  lane I) is once again o f poor resolution. In addition the AGE did not permit the size standard 
and PCR products to migrate at the desired rate. However two distinct bands are visible and 
rather than confirming the correct amplification visually it was confirmed through sequencing
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(Appendix C:A & B). The following is a gel capture of the multiplexed dilution series (Table 
12):





A m p lic o n  1 
256 hp
Figure 12: Multiplex Primers Sets Dilution Series
The purified extract used as template DNA was the sample extract as all previous and subsequent reactions. The 
optimized reagent concentrations and thermocycling parameters were the same as those described in Tables 8 and 9. 
Lane 1 contained the 1500 bp molecular size standard. The dilution series products were contained in the remaining 
lanes as follows: Lane 3, 1:10; lane 4, 1:100; lane 5, 1:1 000; lane 6, 1:100 000; lane 7, 1:10 000; and lane 8, 1:1 000 
000. Lane 2 was blank and did not contain any sample. Lane 9 contained the dilution negative and lane 10 
contained the PCR negative.
Once again the amplieons in Figure 12 are difficult to distinguish between eaeh other. This 
can be attributed to the low resolution capabilities o f the AGE and migratory behavioural 
differences between the size standard and the products. The lanes in which the templates were 
added are not level with each other creating a difference in their vertical displacement.
The sequences performed on the optimized amplification and dilution series products as low 
as 1:10 000 produced the same results as its singleplexed counterparts thus confirming specific 
amplification despite visual discrepancies observed on the AGE (Appendix C: A & B). This 
designed and optimized multiplexed methodology using Amplicon I and II primer sets was 
capable o f successfully and specifically amplifying the desired first two P-globin gene exons and 
thus any inherited genetic variant with a level of sensitivity capable o f detecting DNA dilutions
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o f 1:10 000 (Figure 12, lane 7). All negatives, both dilution and PCR negatives (Figure 12, lanes 
9 and 10) were assured o f purity as no discernable sequences could be produced.
H E M I - N E S T E D  M U L T I P L E X  P C R
The Amplicon III primer set successfully and specifically amplified its desired amplicon of 
227bp (Figure 13, lane 6). The annealing temperature was optimized to 60.0°C (Figure 13, lane 
8) and the reagents were optimally titrated to an efficiency that successfully and specifically 
amplified a purified extract dilution of 1:100 000 (Figure 14, lane 4). The following are the gel 
captures confirming the annealing temperature optimization and the dilution series (Figure 13):
îOObps
:00bps
\m p i ic o n  III
2 2 7  bp
Figure 13:Amplicon III Primer Set Annealing Temperature Optimization:
The purified extract used as template DNA was the sample extract as all subsequent reactions. The reagent 
concentrations were the same as those described in Table 2. The thermocycling paramétrés were the same as Table 
5 with the exception o f annealing temperatures which varied as follows: Lane 6, 55.0 “C; lane 7, 57.8 “C; lane 8, 
60.5 "C; lane 9, 63.0 °C; and lane 10, 65.0 °C. Lane 1 contained a 1500 bp molecular size standard and lane 5 
contains a PCR negative. Lane 2 is blank and lanes 3 and 4 were samples not from this study. The annealing 
temperature, based on the results observed visually in lane 8 to be approximated to 60.0 °C as it had the best 
intensity with the least amount o f  non-specific product.
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500bps
:00bps
A m p lic o n  i
\ m n l i c u n  111 N o n -sp c c il ic
Figure 14: Amplicon III Primer Set Dilution Series
The purified extracts used as template DNA were the corresponding dilution products fi'om Figure 9. The optimized 
reagent concentrations and thermocycling parameters were the same as those described in Tables 10 and 11. Lane 1 
contained the 1500 bp molecular size standard. The dilution series products were contained in the remaining lanes 
as follows; Lane 3, 1:10 000; and lane 4,1:100 000. Lanes 2 and 5 were blank. Lane 6 contained the purification 
negative, which is the PCR negative product fi'om lane 8, Figure 9 but added to the same PCR parameters as those 
described in Tables 10 and 11. Lane 7 contained the PCR negative and the remaining lanes are blank.
Both Amplicon III and Amplicon I can be observed in the dilution series gel capture (Figure 
14, lanes 3 and 4). This is to be expected as the amplified template from Amplicon I primer sets 
is at far greater concentration than a normal initial PCR template and thus not enough o f the 
hemi-nested primer was added. Though if  more primer was to be added it would change the 
concentrations o f the other PCR reagents and the reaction would no longer be optimized. Non­
specific amplicons are observed below the desire product in Figure 14, lane 4 as well as in 6 and 
7 however it is attributed to primer extension products. The negatives produced non specific 
products however when sequenced no discernable sequence could be identified.
The Amplicon IV primer set successfully and specifically amplified its desired amplicon o f 
234bp and the migration o f the size standard matched that o f the desired products. This reaction 
was a success as the specificity was confirmed by sequencing the products. The annealing 
temperature was optimized to 65.0°C (Figure 15, lane 6) and the reagents were optimally titrated 
to an efficiency that successfully and specifically amplified a purified extract dilution o f 1:1 000
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(Figure 16, lane 5). The following are the gel captures confirming the annealing temperature 
optimization and the dilution series respectively (Figures 15 and 16):
300bp
200bp
Figure 15: Amplicon IV Primer Set Annealing Temperature Optimization
The purified extract used as template DNA was the sample extract as all subsequent reactions. The reagent 
concentrations were the same as those described in Table 2. The thermocycling paramétrés were the same as Table 
5 with the exception o f annealing temperatures which varied as follows: Lane 3, 57.8 °C; lane 4, 60.1 °C; lane 5,
63.2 “C; lane 6, 65.1 °C; and lane 7, 66.4 °C. Lane 1 contained a 1500 bp molecular size standard and lanes 2, 9, and 
10 are blank lanes. Lane 8 contained the PCR negative. Lane 6, approximated to 65.0 "C was determined visually 
to be the optimal annealing temperature as is had the best intensity with the least amount o f  non-specific product.
6 7 9 .1 0
300bps-
200bps-
A m p lic o n  II
-A m plicon  IV 
234 bp
Figure 16: Amplicon IV Primer Set Dilution Series
The purified extracts used as template DNA were the corresponding dilution products from Figure 10. The 
optimized reagent concentrations and thermocycling parameters were the same as those described in Tables 12 and 
13. Lane 1 contained the 1500 bp molecular size standard. The dilution series products were contained in the 
remaining lanes as follows: Lane 3, 1:10; and lane 4, 1:100; lane 5, 1:1 000; lane 6, 1: 100 000; lane 7, 1:10 000 
Lanes 2 and 8 were blank. Lane 9 contained the purification negative, which is the PCR negative product from lane 
9, Figure 10 but added to the same PCR parameters as those described in Tables 10 and 11. Lane 10 contained the 
PCR negative and the remaining lanes are blank.
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The desired sized amplicon o f 234bp was produced and though there is significant smearing 
the products have been confirmed as specific through sequencing. This smearing is attributed to 
too much DNA carried over fi*om the products o f  Amplicon II dilution series. This is not o f  
concern as these methodologies are designed to work with degraded DNA and would produce 
products more similar to those in Figure 16, lane 5. Both Amplicon IV and Amplicon II can be 
observed in the dilution series gel capture, as a band o f approximate length o f 339 bp is observed 
in Figure 16, lanes 3 and 4. This is to be expected as primers from the initial amplification may 
still be present or not enough o f the hemi-nested primer was added. It did successfully detect a 
dilution of 1:10 000 (Figure 16, lane 7)
Thus the optimized amplifications and dilution series were sequenced (Appendix C:A & B) 
and they confirmed the sequences obtained by the dilution multiplex PCR (Figure 12). The 
primer sets for Amplicons III and IV successfully produced discernable sequences (Appendix 
C:A & B) for dilutions o f 1:100 000 (Figure 14, lane 4) and 1:10 000 (Figure 16, lane 7) 
respectively. No discernable sequences were produced fi'om the negatives.
The hemi-nested multiplex PCR was optimized and its sensitivity was determined upon 
confirmation that the singleplex reactions o f the Amplicons III and IV primer sets were specific 
and they could detect dilutions o f  1:100 000 (Figure 14, lane 4) and 1:10 000 (Figure 16, lane 3) 
respectively. Its optimal annealing temperature was determined to be 60.0 °C (Figure 17, lane 5) 
and was sensitive enough to detect a dilution of 1:1 000 000 (Figure 18, lane 9). The following 
is a gel capture o f the hemi-nested multiplexed optimized annealing temperature (Figure 17):
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Figure 17: Hemi-Nested Primer Sets Annealing Temperature Optimization
The purified extract used as template DNA was the sample extract as all subsequent reactions. The reagent 
concentrations were the same as those described in Table 2. The thermocycling paramétrés were the same as Table 
5 with the exception o f annealing temperatures which varied as follows: Lane 3, 55.0 °C; lane 4 ,57.8  °C; lane 5,
60.5 °C; lane 6, 63.0 "C; and lane 7, 65.0 °C. Lane 1 contained a 1500 bp molecular size standard and lanes 2 ,8 ,  and 
10 are blank lanes. Lane 9 contained the PCR negative. Lane 5, approximated to 60.0 °C was determined visually 
to be the optimal annealing temperature as is had the best intensity with the least amount o f  non-specific product.
Though the resolution o f the size standard is poor the amplicons are o f great enough 
thickness and fluorescent intensity to assume that both amplifications products, 227 and 234 bp, 
are present. The resolution does not permit differentiation between two amplicons separated in 
length by only seven base pairs. This was distinguished from two much DNA by sequencing 
both products (Appendix C:A & B). Though an artifact is present near lane 9, Figure 17, it is 
clear to see that the PCR negative has not been contaminated.
The purified multiplexed dilution products from Figure 12 were used as templates for the 
hemi-nested multiplex reaction in order to observe an increase in sensitivity capabilities. The 
PCR negative from the multiplex dilution series (Figure 12, lane 10) was again purified and 
reagents added in order to serve as a purification negative to track contaminated reagents or 
improper handling techniques (Figure 18, lane 9). In addition a positive undiluted sample was 
added (Figure 18, lane 1) and as always the PCR negative (Figure 18, lane 10). The following is 
the gel capture o f the hemi-nested multiplex applied to purified multiplex dilution products 
(Figure 18):
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Figure 18: Hemi-Nested Primer Sets Dilution Series
The purified extracts used as template DNA were the corresponding dilution products fi'om Figure 12.The optimized 
reagent concentrations and thermocycling parameters were the same as those described in Tables 14 and 15. Lane 1 
contained the 1500 bp molecular size standard. The dilution series products were contained in the remaining lanes 
as follows: Lane 3, 1:10; lane 4, 1:100; lane 5,1:1 000; lane 6,1:10 000; lane 7,1:100 000; lane 8, 1:1 000 000.
Lane 1 contained the same undiluted extract used in all optimization and annealing temperature reactions. Lane 9 
contained the purification negative, which is the PCR negative product from lane 10, Figure 12 but added to the 
same PCR parameters as those described in Tables 14 and 15. Lane 10 contained the PCR negative.
There are clearly two amplification products o f the same nucleotide length present. The 
negatives were not contaminated and the desired amplicon lengths o f 227 and 234 bp were 
amplified (Figure 18, lane 2). Note that the PCR negative in lane 10 (Figure 18) was ran on a 
separate gel and thus a migration difference exists between the running dye when compare to the 
first nine lanes. Sequencing confirmed these results with those previously conducted in both this 
step and step I.
Overall the hemi-nested successfully improved sensitivity. The subsequent amplification 
allowed the singleplex primer sets to detect and sequence a 10 fold decrease in template 
concentration. The subsequent hemi-nested multiplex amplification produced a detectable 
amplicon from a template dilution o f 1:1 000 000 (Figure 18, lane 8), that was o f similar 
intensity as the undiluted product (Figure 18, lane 1). This represents a 100 fold increase in 
sensitivity compared to the detectable products produced my multiplex alone (Figure 12). The 
sensitivity of the hemi-nested methodology has naturally been increased as each amplicon has to
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specifically hybridize to three primers instead of just two. Thus the sensitivity and specificity 
have been increased with the design and optimization o f the hemi-nested multiplex methodology 
to follow an initial multiplex PCR.
M u l t ip l e x  P r im e r  E x t e n s io n  SNP D e t e c t io n  S y s t e m
The primers were optimized resulting in there addition in equimolar amounts totaling 1 pL of 
primer total. Once the reagents were titrated the pre-purification, the primer extension, and post 
purification methods were carried out as described previously in Protocols.
The methodology was successfully optimized as a multiplex. The results were interpreted by 
Genescan™. It produced homozygous single base extension products corresponding to wild 
type genotype for all positions. The peaks however, due to the chemical dynamics and 
preferential annealing, could not be optimized to provide equal detection intensities with this 
sample. The fragments produced unfortunately do not correspond with their expected mobility. 
HBBSNP26 is detected at a length corresponding to 29.31 bp instead o f 24 bp. HBBSNP6-1R is 
detected accurately, and HBBSNP6-2R is detected at a length corresponding to 32.22 bp. This 
however is not o f concern, and these results are considered accurate as there is a mobility error of 
± 3-6bp and they are within their range o f error. The following is the results obtained on 
GeneScan post-primer extension multiplex optimization (Figure 19):
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Figure 19: Multiplex Primer Extension SNP Detection GeneScan Results 
A. represents HBBSNP26 single base extension product coding for wild type at its corresponding nucleotide 
position, B. represents HBBSNP6-1R single base extension product coding for the reverse compliment o f  wild type 
at its corresponding nucleotide position, and C. represents E1BBSNP6-2R single base extension product coding for 
the reverse compliment o f  wild type at its corresponding nucleotide position.
This design and optimization was a success. This methodology once again increases 
specificity as it incorporates and requires yet another new primer per SNP position to be 
hybridized. Any given SNP at this point has been interrogated by four different primers, one o f 
which. HBBIIAR anneals twice. The sensitivity in terms o f lower concentration o f template 
would not be expected to be increased as an additional amplification has not been introduced. 
Though the detection sensitivity may be decreased with the addition o f more primers as there is a 
finite amount, the necessary fragment size to anneal and detect has been reduced to the size of 
the designed primer plus one nucleotide. Therefore the potential to detect smaller, more 
degraded fragments exists and thus may prove to increase the sensitivity by detecting previously 
undetectable samples.
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CHAPTER 7: DISCUSSION
It is through this project that the objective to design and optimize a multi-step methodology 
o f increasing specificity and sensitivity on modem samples that can be applied to medically 
archived, ancient, and degraded samples was accomplished. The designed methodology to be 
applied is a three step process: 1) Multiplex PCR, 2) Hemi-nested PCR, and 3) Single base 
extension detection o f SNPs using the ABI Prism® SNaPshot^'^ Primer Extension kit. The 
specificity was increased as predicted by annealing multiple primers sets to detect single gene 
sequences and the sensitivity was increased by applying amplified products to a second 
amplification step. This increase in sensitivity and specificity along with the SNaPshot™ 
protocol is hypothesized to allow this methodology to detect the presence o f genetic mutations 
with an emphasis on SNP detection.
The specificity o f the methodology increases as it progresses from step to step as the 
products are interrogated, annealed to, and amplified by a new set o f  oligonucleotide primers o f 
different sequence that must exhibit complete homology with the products nucleotide sequence 
present (Dieffenbach et ah, 1993). The sensitivity increases as the methodology progresses there 
are two amplification procedures whereby the second amplifies the initial amplification’s 
products (McPherson, 2000; Mullis et ah, 1986; Ruano et ah, 1989). This results in the detection 
and sequencing o f  template in a 1:1000000 dilution, an increase of 100 fold detection capabilities 
than with a single amplification procedure. A loss o f sensitivity is to be expected with each 
purification step as the products from the preceding step are diluted and a 100% efficiency of 
column purification is not guaranteed (Stewart et ah, 2003). Furthermore efficiency may 
decrease with each step as carry over reagents unused from the previous step may alter the 
chemical kinetics and product is lost (McPherson, 2000). However these losses o f sensitivity
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and efficiency are negligible if  procedures are performed and the reagents and template are 
stored properly under the proper environmental conditions. When applying this methodology to 
degraded DNA samples contamination is o f the utmost concern (Hofreiter et al., 2001 ;
Willerslev and Cooper, 2005). Thus the precautions outlined in Chapter 2 and sterile working 
environments must be obeyed.
Design and optimization o f primer sets was o f paramount importance. Though described 
more thoroughly in Chapter 3 a balance must be established between specificity and efficiency 
(Dieffenbach et al., 1993). These primer sets were designed for this methodology to amplify 
and analyze the first two exons o f the p-globin gene in order to detect associated 
haemoglobinopathies. This family of gene and diseases was chosen as they obeyed the 
Mendelian pattern o f inheritance, many o f the diseases are prevalent and severe, the diseases 
effect global populations and their distribution, and the majority of diseases are attributed to 
SNPs (Collins, 1984; Weatherall and Clegg, 2001; WHO, 1989). That being said this 
methodology can be modified. The cost, product loss, and risk o f contamination can be 
decreased by removing the electrophoresis steps at the expense o f losing a visual confirmation o f 
desired amplification. However if  well versed and confident in performing the methodology with 
accuracy and precision one can eliminate these electrophoresis steps and simply rely on 
sequencing to confirm specificity of amplification. Furthermore if  one is only concerned with, at 
least initially, detecting the presence of the most prevalent and severe p-globinopathies with in a 
specimen then the sequencing o f multiplex and hemi-nested PCR products can be omitted, and 
one can rely solely the detection capabilities associated with the designed ABI Prism® 
SNaPshof* '̂^ Primer Extension methodology. Considerable time and cost can be avoided.
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This methodology can be applied to detect any known small scale genetic mutations.
Provided that the mutated nucleotide sequence is known, and primers are designed and optimized 
through application to this three step methodology, it is hypothesized that the sensitivity and 
specificity will be capable o f detecting and obtaining genetic sequences from increasingly 
degraded samples. Furthermore by multiplexing the different primer sets one can expand upon 
this study to include multiple genetic mutations in an all inclusive study o f choice. This 
naturally has medical and clinical implications. The multiplexed methodology reduces cost and 
time thus reducing the diagnostic time and increasing overall patient care. Archived and 
fi-agmented patient samples from previous tests can now be repeatedly tested with new disease 
specific primers reducing the impact on the patient and reducing potential travel expenses, a key 
issue in regional care centres when patients live in rural and remote communities.
The increase in specificity and sensitivity of this methodology now provides a tool to 
investigate degrade medically archived and archaeological samples. This methodology can 
easily be adapted in order to validate any historical diagnosis from medically archived samples, 
thus validating early medical studies. Furthermore it can now be applied to detect the 
biomarkers in ancient and degraded samples to validate any previous morphological tissue 
findings or attempt to establish the evolution o f human diseases but their impact on cultures and 
populations (Faerman et ah, 2000; Filon et ah, 1995). Archaeologically one could apply multiple 
primer sets designed to detect multiple diseases in order to investigate the presence o f complete 
spectrums o f disease in ancient populations. The archaeological and clinical applications were 
designed to
The single based primer extension methodology has multiplex capabilites and through its 
automation has the potential to rapidly analyze multiple samples at multiple locations (Syvanen,
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2001). Thus the SNP detection methodology can interrogate large modem amplified fragments 
and data can be applied to linkage mapping or association studies (Kwok, 2001). It is the 
presence o f SNP patterns within non-coding regions that are thought to be in association with 
genes that contribute to the polygenic or multifactorial common diseases whose inheritance 
patterns have yet to be fully identified. These mapping studies can be utilized within the fields 
o f  population genetics and forensics. Many SNPs are conserved within certain populations and 
are stable enough biomarkers to be used to conduct population migration studies. As SNPs do 
occur at high frequencies and are thought to be the factors that contribute to our 0.1% genetic 
individuality (Li and Sadler, 1991; Wang et al., 1998; Wang and Todd, 2003). The sensitivity 
and specificity o f this study allows its application to potentially degraded samples for forensic 
identification.
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CHAPTER 8: CONCLUSIONS AND FUTURE DIRECTIONS
A multi-stepped, multiplexed methodology o f increasing sensitivity and specificity was 
designed and optimized to detect genetic diseases with an emphasis towards SNPs. It consists of 
three steps: multiplex PCR of already extracted and purified DNA, hemi-nested PCR o f purified 
multiplex products, and sequencing of amplifications, followed by single based extension primer 
detection applied to hemi-nested products (see Figure 7). The sensitivity increases with each 
subsequent amplification and the specificity increases as each subsequent step relies on 100% 
homology between the template sequences and the new primer sets. Hence the methodology can 
be applied to degraded and low copy DNA samples. The methodology was designed and 
modeled to detect the presence o f genetic mutations within the first two exons of the P-globin 
gene. These small scale mutations referred to as haemoglobinopathies, served as the perfect 
mutations to design and optimize a methodology around. They follow Medelian patterns o f  
inheritance, have simple molecular genetics, are prevalent, and those that are severe enough to 
affect global populations are the result o f a SNP. All designed primer sets were optimized and 
when viewed by electrophoresis produced amplicons o f desired length. The amplicon specificity 
was validated by sequencing and comparing sequences to the reference sequence.
It was determined that through subsequent amplifications and primer hybridizations that a 
methodology o f increasing sensitivity and specificity was obtained that is capable o f detecting 
genetic disease in degraded tissue samples. In doing so it is hope of the study that this 
methodology will be applied to ancient samples to expand upon previous studies and bridge the 
gap between the diagnosis and study o f  ̂ -haemoglobin variants in both modem and ancient 
specimens (Faerman et al., 2000; Filon et al., 1995). In accomplishing so it is hypothesized that 
further contribute to the research they have started.
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Further methodological validation, however, is required. This reproduction of this study 
must be completed. Furthermore it must be applied to a larger sample size o f human DNA that 
individual’s possessing different genotypic states in order determine the trial sensitivity and 
specificity o f the techniques used. Once established the methodology should be applied to 
medically archived specimens to validate both procedures. Once conducted the methodology is 
to be applied to ancient and degraded samples from areas with high prevalence for 
haemoglobinopathies and/or exhibit pathophysiological and morphological features of 
haemolytic anemias. Finally this study should be further expanded to include diseases that 
exhibit similar pathophysiology findings, inheritance patterns, or are associated with similar 
geographical distribution such as tuberculosis, leprosy, osteoarthritis, or malaria thus creating a 
larger more inclusive diagnostic test to reduce time and cost o f analysis (Gemaey et ah, 2001 ; 
Hershkovitz et ah, 1997; Papathanasiou, 2005).
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APPENDIX A
Reagents Lot#
TNE H I7-06 11/03/06 TM
20% SDS TM 06/01/06
0.39M DTT TM 06/01/06
Proteinase K 43119
Table 21: E.Z.N.A Cycle Pure (United Bioformatica Inc.)
Reagents Lot #
1.5mL tubes 5105
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APPENDIX B
Table 25: Sequence of Primers Used
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APPENDIX C
The following are the sequences produced hy primers used in this study and are compared to their 
corresponding reference sequence. Any discrepancies are highlighted in red.






























E xonl CTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTG 
HBBHIF CTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTG 
H BBIF CTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTG 
HBBIIIAR CTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTG
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HBBIIIF TGACAAGCTGCACGTGGATCCTGAGAACTTCAGGGTGAGTCTATGGGACCCTTGATGTTTT 
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